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Abstract

A STUDY ON THE BIOCHEMICAL AND CELLULAR EFFECTS OF
ENVIORMENTAL TOBACCO SMOKE ON ADULT AND DEVELOPING RAT
BRAIN BIOCHEMISTRY
By Brian Frederick Fuller, Ph.D.
A Dissertation submitted in partial fulfillment of the requirements for the degree of Doctor
of Philosophy at Virginia Commonwealth University.

Virginia Commonwealth University, 2011

Major Director: Andrew K. Ottens
Assistant Professor, Department of Anatomy and Neurobiology

Exposure to environmental tobacco smoke (ETS) has been recognized as a
significant health risk for adults and children. In adults, ETS exposure has been linked to
increased incidences of cardiovascular disease and dementia. In children, exposure has
been linked to behavioral and cognitive deficits. Studies on the effects of ETS in the brain
have been largely epidemiological, and have lacked a defined explanation of the
molecular/biochemical effects of ETS. The present dissertation aims to test whether ETS
exposure leads to altered biochemistry in the adult and developing mammalian brain. A rat
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ETS exposure model was employed to investigate changes at the molecular and cellular
level. In an adult ETS exposure study, we focused on markers of astrogliosis , oxidative
stress, and cell death. We observed altered GFAP suggestive of reactive astrogliosis. Yet,
markers of oxidative and cell stress were unaffected by ETS exposure in the brain regions
examined. Increased degradation of αII-spectrin and dephosphorylation of serine116 on
PEA-15 indicated greater apoptotic cell death signaling in the brains of ETS exposed
animals. β-synuclein was greatly upregulated by ETS, a neuroprotective protein previously
reported to exhibit anti-apoptotic and anti-fibrillogenic properties. We next employed a
rodent model of postnatal ETS exposure to investigate effects on developing cerebellum
using a system biology approach involving mass spectrometry (MS). Proteins at
statistically different abundance between groups were correlated with relevant biochemical
processes and pathways by bioinformatics. ETS responsive data were enriched in elements
associated with all aspects of aerobic respiration. These results were substantiated by
orthogonal molecular measures, along with evidence for increase mitochondrial
biogenesis/fission. These findings suggest an increase mitochondrial density driven by a
demand for ATP. Further exploration of the ETS responsive proteome identified
statistically significant associations of the ETS with neuron projections, in particular axon
associated proteins and synaptic vesicles. Immunotbloting and microscopy experiments
substantiated altered process outgrowth and synaptogenic processes. The presented data
depict a striking modulation in cerebellar formation consequent to ETS exposure and the
energy source to allow that modulation to occur. Our findings could provide a biochemical
and cellular rational for adverse neurological effects observed in ETS exposed children.
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Motivation

ETS, also known as secondhand smoke (SHS) and passive smoking, has become a
recent global concern with known health risk for both non-smoking adults and children (1,
2). ETS is a combination of sidestream smoke from burning tobacco and mainstream
(exhaled) smoke. The chemical composition is remarkably similar between mainstream
smoke, sidestream smoke and ETS (3). Over 4,000 chemical compounds have been found
in ETS (4). However, many chemical concentrations were observed to be ten-fold greater
in sidestream smoke relative to mainstream smoke (5). Of the 4,000 identified chemical
compounds an estimated 250 are known to be toxic or carcinogenic (6).
In 2006, the Surgeon General of the United States released a comprehensive study
of the effects of ETS on toxicology, exposure, reproduction/development, respiratory
effects, cancer and cardiovascular disease. Missing from the report was the under-reported
effects of ETS on the adult brain. ETS effect on neuronal development was reported, citing
evidence of a potential impact; however the report goes on to state that the available data
on the relationship between ETS exposure and CNS function was limited and confounded
and more research was needed (7). Their findings echo those of the World Health
Organization’s earlier report on the effects of ETS on childhood cognition and behavior.
Both reports found that current research was either inconclusive or unclear about the
relationship between ETS and its adverse effects on cognition and behavior among
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children due to significant confounds in experimental procedures and study variations (2),
and emphasize the need for further research.
Research into the effects of ETS has been focused on damage to the heart and lungs
(8). Findings suggest the ETS exposure induces damage that is predominantly a result of
cellular stress caused by increased reactive oxidative species (ROS) and cell death. Few
studies have explored possible biochemical effects on the mature brain as a result of ETS
exposure. Moreover if effects exist would they be detrimental during neuronal
development. The motivation behind my graduate dissertation work is to further explore
this gap in the research, elucidating the biochemical changes caused by ETS exposure in
the adult and developing rat brain.
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Research Objectives

The general hypothesis of my dissertation research is that ETS exposure will
induce biochemical and cellular changes within the adult and developing rat brain.
Previous research suggests that cellular stress, cell death, and other biochemical processes
may be induced by ETS exposure. Proposed is a comprehensive study to test the effects of
ETS in the adult and developing rat pup brain. The enclosed work focuses on the
identification and elucidation of biochemical and cellular domains affected by exposure to
ETS. To test my hypothesis, I pursued the following specific aims:

1. Evaluated cell stress and cell death dynamics within the brain using an in vivo ETSexposure paradigm with adult rats. Numerous proteins involved in cellular stress and cell
death as a result of ETS exposure were identified in the literature. However, the focus of
earlier studies was on non-neuronal tissue such as heart, lungs and cells grown in culture.
For this aim I characterized these and other proteins within the brain following ETS
exposure in the adult rat (Chapter 2). Experiments involved a combination of immunoblot
and mass spectrometry analyses.

2. Evaluated novel biochemical pathway in the developing rat brain affected by ETS
exposure during cerebellar development using an in vivo ETS-exposure paradigm with rat
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pups. Initial epidemiological studies have suggested a direct relationship between ETS
exposure, hyperactivity disorders and cognitive/behavioral deficits. The ETS exposure
model was adapted for rat pups in order to examine biochemical and cellular effect on
cerebellar development. Differential proteomics using a label-free method established in
our laboratory provided a novel holistic examination of effects on the developing rat
cerebellum. A systems biology approach was employed to interpret and substantiate the
mass spectrometry results. Microscopy further extended our results into the cellular
domain.

CHAPTER 1
EFFECTS OF ENVIRONMENTAL TOBACCO SMOKE IN ADULT BRAIN
1.1. Epidemiology of environmental tobacco smoke in adult brain.
Environmental tobacco smoke has been well documented for its effect on the
pulmonary and cardiovascular system. Non-smokers exposed to ETS have a 25-30%
increased risk for heart disease, with about 46,000 deaths annually. The increase in lung
cancer risk for non-smokers exposed to ETS is between 20-30% with an estimated 3,400
deaths (1). While the negative effects of ETS have been well defined in the heart and lungs
of exposed non-smokers what is less clear is the relationship between ETS and its effect on
the brain.
The overall relationship between smoke and neurological disorders can be traced
back to the 1950s. In 1959 Dorn published a study reporting an inverse relationship
between cigarette smoking and Parkinson’s disease (PD) risk (9). Since that time the
debate on the effects that smoke has on the brain has been hotly debated. Two types of
experimental paradigms have been utilized in studies on the effects of ETS on the brain.
The first type relies on self-reported assessment surveys looking at the amount and
duration of ETS exposure. The second relies on blood measurements of cotinine to
determine the amount of ETS exposure. Cotinine is a metabolite of nicotine that has been
widely used as a biomarker of ETS exposure in non-smokers. Both types of studies have
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been used to examine the relationship between ETS and various neurological disorders
such as dementia and Alzheimer’s disease (AD).
A connection between ETS and dementia was first reported in 2007 at the annual
meeting of the American Academy of Neurology by a research group at the University of
California at San Francisco (10). Recent work has determined that cigarette smokers in
older adults can lead to an approximate doubling in the risk of dementia (11). The current
thought on the connection between ETS exposure and dementia is an increase in
cerebrovascular disease (12). ETS has been well documented in the literature to cause
negative vascular changes that can range from platelet aggregation to stroke (13, 14).
Barnes et al. used this association as the rational for their 2010 study of ETS and dementia
risk in older adults. They hypothesized that lifelong exposure to ETS among older adults
who have underlying clinical or subclinical vascular disease could result in an increase risk
of dementia. Their findings demonstrated a threefold increase of dementia risk in subjects
who had a high level of exposure (self-reported) to ETS, and a 25% increase in carotid
artery stenosis. From these finding the authors conclude that ETS, when combined with
undiagnosed cardiovascular disease, can lead to an increase risk of dementia (11).
Llewellyn et al. published a study exploring a possible link between cotinine
measurements and cognitive impairment. Their results demonstrated that high levels of
cotinine in non-smoking adults associated with increased odds for cognitive impairments
(15). The authors did point out that previous studies in which a non-significant trend was
reported between self reported exposure and dementia risk could have been due to the bias
of self-reported data. The risk of Alzheimer’s disease as a specific form of dementia has
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only been examined in smokers (16). Tyas et al. found a association between smokers and
AD risk, with a dose dependent relationship between the smoking and AD risk as well as
an increased risk for cerebrovascular disease and dementias (16).

1.2. Molecular effects of environmental tobacco smoke exposure.
Environmental tobacco smoke is a combination of 15% mainstream smoke and
85% sidestream smoke each of which contains a large compilation of toxic and
biologically-reactive chemicals. Mainstream smoke consists of a particulate and gas
phases, both containing a high number of free radicals (17). Heavy metals are found in
mainstream smoke as well as toxins such as ammonia, cresol, catechol, carbon monoxide,
lead, ketone, nitiric oxide, phenol, styrene, toluene, and butane (18). Sidestream smoke has
a similar chemical composition to mainstream smoke, but is made up of a greater
concentration of the different components (5). Studies on sidestream smoke revealed that
animals exposed to sidestream smoke only had higher concentrations of
carboxyhemoglobin, nicotine and cotinine in their blood relative to those exposed to
mainstream smoke only. It was also found that sidestream condensates were more
tumerogenic than mainstream condensates (19, 20).
Cell Stress
Side stream and mainstream smoke contain reactive, long lived free radicals (21,
22). Gaseous free-radicals and other chemicals will induce production of reactive oxygen
species (ROS) in the body; e.g., superoxide anions, reactive aldehyde species, nitric
oxides and peroxynitrite (21). Polycyclic aromatic hydrocarbons (PAHs) can generate
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ROS, are carcinogenic and are potent atmospheric pollutant, are also in mainstream
smoke (23). Cigarette smoke has been shown to promote protein oxidation in vivo
resulting in oxidative stress along with the reduction of circulating antioxidants (24-26).
Further, cigarette smoke contains heavy metals such as cadmium (27) that are detrimental
to the nervous system (28), easily crossing the blood brain barrier and catalyze freeradical reactions to promote cell death by apoptotic and necrotic pathways (29).
Oxidative stress can result in tissue damage when pro-oxidants (ROS) become
prevalent over anti-oxidants. For example, superoxide anions produced from excess
mitochondrial respiration will cause oxidative damage by nitrosylating tyrosine residues
on proteins. Another ROS, hydrogen peroxide, is a dangerous byproduct of oxidative
metabolism that causes cytotoxic effects in cells if not removed quickly. Hydrogen
peroxide has been found to cause increase cell death in an aged mouse strain of cultured
astrocytes (30). Free radicals contained within cigarette smoke can activate redox
sensitive transcription factors such as nuclear factor-kappa B (NF-kB), which can lead to
the transcription of pro-inflammatory genes in the brain (31), to promote glial activation
as previously monitored by increased levels of glial fibrillary acidic protein (GFAP) (32,
33). Reactive gliosis has also been suggested as a possible consequence of prenatal and
perinatal exposure to ETS, though; this suggestion was based on observed changes in cell
size rather than molecular markers (34). Mazzio et al. have found cigarette smoke to
inhibit inducible nitric oxide synthase (iNOS) in glia (35). iNOS is an enzyme responsible
for the generation of nitric oxide. Nitric oxide is a potent signal in many diverse
physiological processes at low concentrations but at high concentrations may cause DNA
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damage and cell death (36). iNOS inhibition can be used as another indicator of oxidative
damage within examined tissues in response to cigarette smoke exposure. In all, cigarette
smoke promotes ROS within the cell which must be counteracted to prevent oxidative
damage to cellular structures by anti-oxidants.
The anti-oxidant defense system functions to process ROS and limit the toxicity.
For example, ascorbic acid is an anti-oxidant that acts as a free radical scavenger in
plasma, and is a frontline defense against ROS. Research has shown that anti-oxidant
levels are reduced by ETS exposure, disabling the body’s natural defense against ROS
damage. Ascorbic acid levels in blood were reduced in children exposed to ETS in the
home - even with minimal exposure (37). Another study by Mendez-Alvarez et al. found
that cigarette smoke inhibited the activity of the anti-oxidant catalase in the brain (38).
Active smoking was also found to affect the anti-oxidant enzymes superoxide dismutase
and glutathione peroxidase, which results in a significant increase in oxidative stress (39).
These data highlight an important detrimental effect of ETS – not only to induce ROS but
to also cripple the body’s natural defenses against ROS resulting in oxidative damage.
Cell Death
The two well defined cell death processes are necrosis, a non-programmed,
involuntarily event and apoptosis, which is a controlled form of cell death that is triggered
voluntarily by activation of discrete molecular pathways (40). In contrast to necrosis,
morphologically and biochemically, apoptosis is a programmed form of cell death – the
ordered process of turning off and dismantling the cell. Apoptosis can be triggered by the
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immune system, signaling cells that have been damaged beyond repair with Fas or TNF
ligands. ETS exposure has been shown to induce increased apoptosis in lung tissue due to
irreversible cell damage (41), which can be monitored by the activation of caspases.
Caspases are a family of calcium-independent cysteine proteases integral to apoptosis
pathways. Caspase 8 is activated when an extrinsic “death signal” is received at the cell
membrane by Fas or TNF receptors. Conversely, caspase 9 is activated when an intrinsic
signal is received. The extrinsic and intrinsic signal cascades both activate caspase 3,
which is the primary executioner caspase. Caspase 3 will cleave important cellular
proteins leading to the morphological changes observed during apoptosis. Though
caspase activation is specific to apoptosis, it is also important to note that calpains are
also activated during apoptosis leading to further protein degradation. Kuo et al. made a
similar connection between ETS exposure and apoptosis in rat heart muscle cells,
observing that adult rats exposed to ETS had increased levels of caspase 3, Fas, and the
active form of caspase 9 in their tissue (42). Their work demonstrates a molecular basis
for apoptotic cell death and tissue damage as a result of exposure to ETS.
In chapter two we present our first study on the molecular and cellular effect of
ETS on the brain, which were begun with adult animals. Given limited literature on the
effects of ETS on the brain our initial aim was to demonstrate a measurable effect of ETS
exposure relative to control on the mature rat brain. Our hypothesis was based on the
literature suggesting potential oxidative stress, gliosis, and apoptotic cell death. Both
oxidative stress and cell death were previously identified as possible molecular mechanism
for negative effects of ETS on coronary and pulmonary systems. It is also of note that our
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lab also explores the molecular effects of traumatic brain injury, from which we built the
tools used in our ETS studies on the adult rat brain.

CHAPTER 2
EFFECTS OF ENVIRONMENTAL TOBACCO SMOKE ON ADULT RAT BRAIN
BIOCHEMISTRY
2.1. ABSTRACT
Environmental tobacco smoke (ETS) has been linked to deleterious health effects,
particularly pulmonary and cardiac disease; yet, the general public considers ETS benign
to brain function in adults. In contrast, epidemiological data has suggested that ETS
impacts the brain and potentially modulates neurodegenerative disease. The present study
begins to examine yet unknown biochemical effect of ETS on the adult mammalian brain.
In the developed animal model, adult male rats were exposed to ETS three hours a day for
three weeks. Biochemical data showed altered GFAP levels as a main treatment effect of
ETS suggestive of reactive astrogliosis. Yet, markers of oxidative and cell stress were
unaffected by ETS exposure in the brain regions examined. Increased proteolytic
degradation of αII-spectrin by caspase-3 and the dephosphorylation of serine116 on PEA-15
indicated greater apoptotic cell death modulated by the extrinsic pathway in the brains of
ETS exposed animals. Further, β-synuclein was upregulated by ETS, a neuroprotective
protein previously reported to exhibit anti-apoptotic and anti-fibrillogenic properties.
These findings demonstrate that ETS exposure alters the neuroproteome of the adult rat
brain, and suggest modulation of inflammatory and cell death processes.
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2.2. INTRODUCTION
Exposure to environmental tobacco smoke (ETS) is a known health risk in adults
and children. A recent U.S. Surgeon General Report (2007) reviewed the causal
relationship of ETS with disease, particularly pulmonary and cardiac. Neurological effects
were deemed inconclusive, with the stated need for more research (7). Yet, ETS is a
known risk factor for cerebrovascular disease (43-45). Further, epidemiological studies
recently indicated ETS as a risk factor for Alzheimer’s disease (AD) ((10, 15). At the same
time, ETS appears to decrease risk for Parkinson’s disease (PD) (46). Despite an apparent
clinical impact on the adult brain, the molecular influence of ETS is underexplored, and is
largely considered benign.
ETS administered has been shown to alter morphology during primate brain
development (34). ETS exposure caused an increase in smaller glial cells suggestive of
reactive astrogliosis. Astrogliosis was also observed in the developing brain after prenatal
nicotine exposure, with increased glial fibrillary acid protein (GFAP) levels in the
cerebellum and hippocampus of offspring (33). Importantly, GFAP levels remained
elevated out to postnatal day 60, and deficiencies in basic sensory motor skills were
observed (32), a long term, functional effect. Susceptibility to ETS may differ between the
developing and mature mammalian brain, but these data raise the potential of an astrocytic
response following adult ETS exposure.
Chemicals from ETS have also been found to influence apoptotic processes in cell
cultures. Apoptosis is a cell death processed that can be triggered via internal or external
cues. Regulation of extrinsic apoptosis involves PEA-15 (phosphoprotein enriched in
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astrocytes), an inhibitory protein that binds FADD (Fas-associated protein with death
domain) when phosphorylated on Serine 116 (S116) (47). Dephosphorylation leads to
caspase 3 activation and subsequent protein cleavage events. One such cleaved protein is
αII-spectrin, the cleavage product of which is a known marker selective for apoptosis in
neurons (48). ETS chemical extracts induced apoptosis in cardiac cells, with increased
Fas and active forms of caspases 3 and 9 (41, 42). In contrast, nicotine administration
alone was neuroprotective in spinal cord neurons challenged by apoptosis inducing
arachidonic-acid. Activation of caspases 3, 8 and 9 and release of cytochrome c were all
reduced with nicotine relative to vehicle (49, 50). These data illustrate how the effects of
ETS, with a complex chemical formulation (51), may not be sufficiently modeled by
nicotine administration alone. Different components of ETS may induce competing proand anti-apoptotic responses.
Given the aforementioned relationships between ETS exposure and the molecular
processes astrogliosis and apoptosis in other systems, we present this initial study
examining molecular effects in the adult mammalian brain. The glial selective marker
GFAP and the neuronal selective caspase 3 proteolytic fragment of αII-spectrin were
employed to characterize these processes across multiple brain regions. Mass spectrometry
methods were also employed to test for ETS effects on the neuroproteome. This initial
assessment focused on the limbic areas frontal cortex and hippocampus as well as
cerebellum. Hippocampus and cerebellum were areas shown affected by ETS in
developing brain, and limbic regions, such as frontal cortex and hippocampus, are known
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to be affected in smokers (52). Further, these limbic areas are affected by increased
apoptotic and gliotic pathology in adult onset neurodegenerative disease (53-55).

2.3. EXPERIMENTAL PROCEDURES
Animal Procedures and Tissue Collection- Ten-week old male Sprague Dawley rats
(Harlem, Indianapolis, IN) were acclimated to the laboratory for four days prior to
exposure. Rats were kept under a controlled environment and housed two to a cage. Food
and water were provided ad libitum except during exposure when food was removed. No
enrichment was provided to either the control or treated groups.
Following acclimation, rats were placed in a Teague TE-10 smoke exposure system
(56) for three hours per day over a three week period. The ETS group (n=8) was exposed
to a mixture of 15% mainstream (aspirated through filter) and 85% sidestream smoke
diluted with air to a concentration of 5 mg/m3 of respirable suspended particulate (RSP).
The control group (n=8) was exposed simultaneously to room air. During each exposure,
twenty Kentucky 3R4F reference cigarettes (University of Kentucky, Lexington, KY) were
smoked at a rate of one puff per minute, two seconds per puff (35 cm3) for eight puffs in
nine minutes per cigarette. This model provided comparable airborn exposure as
experienced in a 50 m3 household room (0.7 air changes per hour) with a smoker
consuming 2 cigarettes per hour over 10 hours (per tables in (57)), which was validated by
repeated mass measurements of respirable suspended particles.
A day after the last ETS exposure, rats were decapitated under deep anesthesia (5%
isoflurane for 5 minutes). Frontal cortex, hippocampus and cerebellum were dissected, and
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snap frozen in liquid nitrogen. All procedures conformed to the United States Public
Health Service policy with approval of the Institutional Animal Care and Use Committee.

Statistical analysis- Experiments were performed with n=4 biological replicates per
group. Multivariable datasets were analyzed by a two-way repeated measure ANOVA
with the Holm-Sidak distribution test and Bonferroni correction. Single variable datasets
were analyzed by a t-test with a Kolmogorov-Smirnov distribution test. A Q-test was
applied to identify outlier values.

Immunoblotting- Lysates were prepared from the brain tissue as described before (58).
Protein concentration was determined via Bio-Rad DC Protein Assay (Hercules, CA).
Protein-balanced samples were prepared for SDS-PAGE, 4-20% Tris-glycine gel, in a twofold Tris-glycine loading buffer (Invitrogen, Carlsbad, CA). Samples were heated for 90 s
at 90°C, and centrifuged for 2 min. Following electrophoresis, separated proteins were
transferred to polyvinylidene fluoride membranes by the semi-dry method. Membranes
were probed with primary antibodies to: GFAP (Millipore, Billerica, MA) at 1:5,000; αIIspectrin caspase-3 breakdown product (University of Florida, Gainesville, FL) at 1:2,000;
β-synuclein (BD Biosciences, San Jose, CA) at 1:20,000; α-synuclein (BD Biosciences) at
1:1,000; heat shock protein 70 (Stressgen, Victoria, BC) at 1:2,500; inducible nitric oxide
synthase (BD Biosciences) at 1:5000; superoxide dismutase 1 (Millipore) at 1:500; β-actin
(Sigma-Aldrich, St. Louis, MO) at 1:2000. The blots were then incubated with a
biotinylated-conjugated secondary antibody followed by a streptavidin alkaline
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phosphatase conjugate. Bound antibodies were visualized by colorimetric development
with the phosphatase substrate BCIP/NBT (KPL, Gaithersburg, MD). Quantitative
evaluation of protein levels was performed via densitometric analysis of 16-bit grayscale
images using Image J software (National Institute of Health, v 1.6, Bethesda, MD).

Mass spectrometry- Fresh-frozen hippocampus tissues were prepared for IMAC
(immobilized metal ion affinity chromatography) analysis as described previously (59).
Briefly, Trizol reagent (Invitrogen) was employed for protein extraction per the
manufacturer instructions. The protein pellet was resuspended with phosphatase inhibitors
(Sigma-Aldrich). Protein concentration was determined by DC protein assay. Protein (50
µg) was then reduced and alkylated with DTT and iodoacetamide, respectively, and
digested with endo-Lys-C (Roche, Indianapolis, IN) overnight at 37°C. ETS exposed and
control group samples were reacted for 2 h with heavy and light methanolic HCl,
respectively, as described previously (60). Sample pairs were loaded onto a Poros MC
(PerSpective Biosystems, Framingham, MA) packed IMAC column, and separated as
described previously (59). The phosphopeptide enriched fractions were separately resolved
by reversed-phase gradient separation from 0.7% to 28% acetonitrile/0.2% formic acid in
150 min online with a ThermoElectron (San Jose, CA) LTQ Orbitrap XL with electron
transfer dissociation source (61). ETD produced c/z· spectra were searched against a
Uniprot Rattus protein database (v14.1) and the reversed image of that database with the
OMSSA search engine, and were filtered for a 1% false-detection rate. Integrated peak
areas were used to quantify the deuterated and non-deuterated forms of the PEA-15
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apoptosis-signaling phosphopeptide.

2.4. RESULTS
ETS exposure animal mode- The ETS exposure model developed for this study
produce no notable stress in the research animals. Exposed and control animals were
handled daily. Normal curiosity to a change in environment was observed for all animals.
Animals exposed to ETS displayed less spontaneous movement during exposure than
controls, but became immediately alert and explorative whenever the ETS exposure ceased
(prior to any other change in environment). The pre-exposure mean body mass for the
ETS animal group was 5 g less than the control group, and finished 8 g less 3 weeks later.
Overall, no statistical difference in weight gain rate was observed between the two groups.
ETS induces GFAP expression in brain- GFAP was modulated as a main treatment
effect of ETS exposure (p = 0.003). Multiple comparison analysis also showed an ETS
treatment within brain region interaction on GFAP expression (Fig. 2-1) that was
statistically significant in hippocampus (p = 0.001), and cerebellum (p = 0.02). Frontal
cortex exhibited a lower, non-significant (p = 0.09) interaction, with the data exhibiting a
bimodal distribution of individual values, confirmed by replicate assay to rule out
experimental error.
ETS affects markers of apoptosis, not cell stress- ETS exposure also had a main
treatment effect on increased caspase-3 proteolysis of αII-spectrin in the adult rat brain (p
< 0.001) in exposed animals. There was also an interaction of ETS treatment within brain
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Fig. 2-1: Effect of ETS on the astrogliosis marker GFAP in the adult rat brain. (A)
GFAP immunoblot analysis as a marker of astrogliosis in three regions of the adult rat
brain after a 3-week ETS or room air exposure. (B) Normalized densitometric
quantification of GFAP with β-actin used as a loading control. Symbols indicate significant
differences from control (* p ≤ 0.02, and ** p < 0.001) by a repeated measures ANOVA
multiple comparison of treatment x brain area.
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regions (Fig. 2-2), with a statistically significant increase in frontal cortex (p = 0.001). The
breakdown product was up for ETS treatment within hippocampus and cerebellum as well,
but the observations were not statistically significant (p = 0.03 and p = 0.4, respectively).
Mass spectrometry analysis revealed dephosphorylation of PEA-15 at S116 (p < 0.001) in
the hippocampus of ETS exposed animals. Site specific phosphorylation was confirmed
with the selective pattern of c and z· (ETD) fragment ions (Fig. 2-3). Additional
immunochemical studies showed that levels of the oxidative and cell stress associated
proteins (data not shown), inducible nitric oxide synthase (iNOS), superoxide dismutase 1,
and heat shock protein 70 kDa (HSP70) were unaffected by ETS exposure across the three
brain regions examined in this study.
ETS induces synuclein protein expression- Mass spectrometry analysis also
revealed a large quantitative difference in synuclein protein abundance, though the data
lacked isoform specificity. Further immunochemical analysis determined that it was the
neuroprotective isoform β-synuclein which increased (p < 0.001) in the hippocampus of
ETS exposed animals relative to room-air controls (Fig. 2-4). In contrast, aggregate
forming α-synuclein expression trended slightly lower among ETS exposed animals, but
was not a statistically significant difference.

2.5. DISCUSSION
ETS exposure was verified to influence the adult rat brain neuroproteome in this
investigative study. Molecular effects were observed across multiple brain areas while
animal growth, as a basic physiological measure, was unaffected. Changes in protein
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Fig. 2-2: Effect of ETS exposure on a neuronal apoptosis marker in the adult rat
brain. (A) Immunoblot analysis of the neuronal αII-spectrin caspase-3 breakdown product
as a marker of apoptosis in three regions of the adult rat brain after a 3-week ETS or room
air exposure. (B) Normalized densitometric quantification of the breakdown product with
β-actin used as a loading control. Symbols indicate significant differences from control
(* p ≤ 0.02, and ** p < 0.001) by a repeated measures ANOVA multiple comparison of
treatment x brain area.
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Fig. 2-3: Effect of ETS exposure on DISC inhibiting dephosphorylation of PEA-15.
(A) Example electron transfer dissociation spectrum of c/z. fragment ions selectively
identifies the phosphorylated S116 site, with the phosphorylation state assessed for ETS
exposed (B) and control (C) groups by chromatographic peak integration.
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Fig. 2-4: Effect of ETS exposure on synuclein proteins in the adult rat hippocampus.
(A) Immunoblot analysis was performed with antibodies against α- and β-synuclein with
hippocampal tissue from adult rat brain after a 3-week ETS or room air exposure. (B)
Normalized densitometric quantification of synuclein proteins with β-actin used as a
loading control. Symbol indicates a significant differences from control (** p < 0.001) by a
t-test.
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markers suggested modulated astrogliosis (GFAP), apoptotic cell death (cytoskeletal
degradation of neurons, and DISC complex formation), and the over-expression of βsynuclein as a potential neuroprotective response.
ETS induces astrogliosis in adult rat brain- ETS resulted in modulation of GFAP
across the three brain areas examined. GFAP levels are a known marker of astrogliosis in
damaged brain (62). The ETS induced difference in GFAP was statistically significant as a
main effect and as a regional interactive effect in hippocampus and cerebellum. The adult
GFAP results correlate with previous observations of increased GFAP expression
consequent to prenatal nicotine exposure (32, 33) and an increase in cell density in the
developing brain from ETS (34).
ETS induces apoptosis in adult rat brain- Apoptotic cell death was demarked by
greater caspase 3 degradation of neuronal αII-spectrin in the adult rat brain. Increased
degradation was a main effect of ETS treatment; though, multiple comparison analysis
showed statistically significant treatment within region interactions for frontal cortex.
Apoptosis has been reported as a direct result of cigarette smoke induced cell stress in
other organs and cultures. ETD tandem mass spectrometry revealed the dephosphorylation
of PEA-15 at S116 in ETS exposed hippocampus, suggesting the activation of the extrinsic
apoptotic pathway, which was previously found activated by ETS in cardiac cells (41, 42).
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Neuroinflammation can induce the extrinsic apoptotic pathway through the
production of reactive oxygen species (ROS). The ROS nitric oxide is often, though not
always (63, 64), induced from increased iNOS expression. In this study, ETS treatment
showed no effect on iNOS expression by immunoblot. While ETS may induce
astrogliosis, it separately may be suppressing iNOS expression in glia. Cigarette smoke
condensates were previously observed to inhibit iNOS in glial cultures (35). Superoxide
dismutase 1 (SOD 1), an antioxidant that is also upregulated as a response to brain ROS
(65). SOD 1 expression, like iNOS, was unaffected by ETS exposure in this study. Rats
exposed to direct smoke (as opposed to ETS) have been shown to express significantly
greater levels of HSP70 in brain (66), pulmonary airways (67), and mammalian cell
cultures (68). HSP70 is a neuroprotective protein upregulated during times of cell stress;
however, in this study, HSP70 expression was also found to be unaffected by ETS
exposure in replicate assays. Together, these data suggest that ROS is not induced by ETS
exposure in the brain areas studied with this model, and is, therefore, not likely the causal
factor promoting apoptosis.
ETS affects β-synuclein protein expression- β-synuclein expression was
upregulated in ETS exposed animals. α- and β-synuclein are functionally distinct, with
the α isoform prone to Lewy body forming aggregation found in the PD brain (69). In
contrast, β-synuclein is immune from aggregation due to its lack of a non-amyloidogenic
domain (70). β-synuclein has shown anti-apoptotic properties through down-regulation of
p53 expression (71). β-synuclein has also been shown to restore the anti-apoptotic function
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of α-synuclein (71). The marked increase in β-synuclein levels observed here may be a
neuroprotective response to the observed neuronal apoptosis.
Smoking has long been known to reduce PD incidence (9) in a dose dependent
fashion (72, 73). A recent epidemiological study showed ETS as having a similar effect on
PD incidence (46). Many studies have explored a connection between smoke exposure and
PD neuroprotection. This is the first study to demonstrate increased expression of
neuroprotective β-synuclein by ETS, which could be involved in reduced PD incidence. βsynuclein is known to inhibit α-synuclein aggregation in addition to its anti-apoptotic
properties (71, 74). A recent study, pointed to nicotine as an active agent that retards the
fibrillogenic activity of α-synuclein (75). Future work will examine β-synuclein as an
intermediate in PD relevant brain regions.
In conclusion, the results from this study demonstrate a main treatment effect of
ETS on adult rat brain biochemistry, which begins to dispel the notion that ETS exposure
is benign to the adult mammalian brain. The data point to modulated apoptosis and
astrogliosis via increases in markers of these processes, but without the influence of ROS.
The data also suggest differences among individual animals that may signify variable
susceptibility to ETS effects. β-synuclein expression is significantly increased by ETS
exposure, which may be a neuroprotective response with a potential benefit relative to PD.
Future work will investigate the induction of apoptosis by ETS and its connection with the
increase in β-synuclein in the adult rat brain.

CHAPTER 3
ENVIRONMENTAL TOBACCO SMOKE IN BRAIN DEVELOPMENT
3.1. EPIDEMIOLOGY OF ENVIRONMENTAL TOBACCO SMOKE IN
CHILDREN
The National Cancer Institute and the World Health Organization released a 1998
report on the effects of ETS on childhood cognition and behavior. Their report concluded
the existing research was insufficient to establish a relationship between ETS and adverse
effects on cognitive and behavior domains among children. A lack of clarity resulted from
significant confounds in epidemiological experimental procedures and study variations (2).
Six years later it was estimated that 11% of all US children age 6 and under were still
exposed to daily ETS (57). Reports that focused on cognitive development assessed a wide
range of variables - scores for reading and language skills, grade retention and standardized
tests that measure specific skills like speech, intelligence and special abilities. A number of
reports found varying degrees of association between ETS and cognitive development (7679). Roeleveld et al. found that exposure to ETS during pregnancy and the first 6 months
postpartum led to an increased risk of mental retardation (80). These findings are
significant since 50% of mothers who quit smoking during pregnancy resumed within 6
months after giving birth (81). Fried et al. observed that postnatal ETS exposure, led to
impaired language abilities (82). Other studies using multiple standardized behavioral and
learning aptitude tests have found a statistical difference in approximately 80% of tests
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administered. However, there also have been a number of reports that could not
demonstrate an association between ETS exposure and increased cognitive deficits (8385).
Studies linking ETS exposure and behavioral problems in children have been
limited. Weitzman et al., 1992, reported a direct correlation between heavy maternal
smoking and behavioral problems (86). Similar findings were reported by Makin et al.
where children exposed to ETS were reported to have more behavioral problems than
children who were not exposed to ETS (77). Fergusson et al. also demonstrated a
statistically significant association between ETS exposure and childhood disruptive
behaviors including conduct problems and attention deficit behaviors (87). These findings
appear to correlate with results from Wakschlag et al. who found that maternal smoking
lead to an increase in behavioral problems in male offspring (88). Other behavioral
disorders such as attention deficit hyperactivity disorder (ADHD) have also been linked to
ETS exposure (89, 90).
The epidemiology suggests that ETS may cause cognitive and behavioral problems
in children; however, not enough research has been conducted in this vital area to
conclusively demonstrate this fact. The need for more research was emphasized by the
U.S. Surgeon General’s report on ETS exposure (7). It is of particular interest that during
the time period when researches were examining a link between ETS and developmental
issues, others were beginning to link the cerebellum with some of the same cognitive and
behavioral domains.
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3.2. CEREBELLUM ARCHITECTURE
The cerebellum is a highly folded brain region that is structurally conserved across
mammals, including humans. Distinct layers can be observed within the folded cortex of
the cerebellum. The outermost layer of the cerebellum is the molecular layer, which
contains the dendritic arbors of Purkinje cells, and parallel fibers, the excitatory granular
cell axons. The molecular layer also contains stellate and basket cells, which are inhibitory
interneurons that synapse onto Purkinje cells. Below the molecular layer is a single-cell
thick layer of Purkinje cells, which receive input from parallel fibers and form the
inhibitory output of the cerebellar cortex. Below the Purkinje layer is the granular layer,
which is the most densely packed compilation of neurons in the entire brain. Below the
granular layer are white matter tracts that contain the myelinated axons entering the
cerebellar cortex. Input into cerebellum occurs via climbing fibers and mossy fibers.
Climbing fibers originate from the inferior olivary nucleous and synapse onto multiple
Purkinje cells, but each Purkinje cell can only receive input from one climbing fiber.
Mossy fibers on the other hand terminate onto granular cells. The organization of layers
and connections of the cerebellum are relatively homogenous compared with other brain
regions. The cerebellum matures later in development, much like the prefrontal cortex.
Much of molecular layer formation, the most significant synaptic organization in the
cerebellum, occurs after birth in both rats and humans.
The cerebellum has long been recognized for its control of muscular coordination
of complex movements and motor learning. However, neurobehavioral, neuroimaging, and
clinical studies over the past twenty years have begun to identify the cerebellum as critical

30
to cognitive functions partially involving language and attention (91). Neuroimaging
studies have found a direct relationship between increased activation of the dorsolateral
prefrontal cortex and the cerebellum during the completion of a cognitive task. This coactivation has been seen during a wide variety of cognitive assessment task such as the
verb generation task (92), verbal fluency task (93), Wisconsin card sorting task (94), and
various other non motor, working memory tasks (95-97). The activation of the dorsolateral
prefrontal cortex and the cerebellum are critical parts of a neuronal circuit when a
cognitive task is difficult for the participant, novel, under new experimental conditions, if a
quick response is required, and if the participant must concentrate on the task at hand (98).
Similar, findings were found in patients who were injured in the cerebellum. These patients
fail typical tests associated with the prefrontal cortex such as verb generation (99), verb
frequency (100), or working memory tasks (99). However cerebelluar injury patients have
no trouble completing the Wisconsin card sorting test (101). The cerebellum has also been
linked to attention and hyperactivity disorders such as ADHA, which incidentally have
also been linked to ETS exposure.
Often overlooked aspects of ADHD are motor control issues. Studies have found
that many ADHD children also have poor motor control (102, 103). It has also been
observed that boys with ADHD have smaller cerebellums relative to normal controls (104,
105). The cerebellum has been shown to be vulnerable to perturbations during
development. As early as 1975 Lynch et al. found an association between malnourishment
of pregnant rats during gestation and lactation produced prodigy who showed signs of
motor control deficiencies (106). Further quantitative stereological procedures at the light
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and electron microscope levels found a 31% decrease in the synapse-to-neuron ratios of the
granular layer, and a decrease in both the size and amount of Purkinje cells in rats who
were undernourished during early postnatal life (107, 108). Exposure to alcohol was also
reported to cause a decrease in Purkinje cell population of neonatal rats but not gestating or
adult rats (109). The vulnerability in the postnatal state was further explored with x-ray
irradiation and under nourishment induced injury in the cerebellum. These experiments
discovered a vulnerable period from birth through postnatal day (PD) 21 in rats, where
damage to the cerebellum resulted in sustained and functionally significant changes (110).
Damage to the cerebellum following PD8 resulted in no significant motor deficits, but
instead induced hyperactivity (111). Children with cerebellar hypoplasia exhibited
significant impairments, but the most notable area affect was attention (91). Combining
all the evidence, we hypothesized that exposure to ETS during the vulnerable period of
cerebellar development could result in perturbed formation, which consequently may be
involved in cognitive and behavioral deficits potentially impacted by ETS.

3.3. SYSTEMS BIOLOGY
Systems biology is the holistic study of biological systems. Involved is the study of
interactions from how a group of proteins act in a metabolic pathway, to how that
metabolic pathway interacts with other pathways in a cell, to how that cell interacts with
the cells around it, and so on. The key is the identification of the interactions and the
elements that comprise them. In 2004, Weston et al. listed and explained five key elements
that allowed for the emergence of systems biology as a field of study. The first was the
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completion of the human genome project, which led to further discoveries on the mRNA
and proteins in individual organisms and cell types. The second was the rise of crossdisciplinary biological science, which has allowed for the combined knowledge of
scientist, engineers, mathematicians, chemists and computer sciences. Next was the
internet followed by the idea of biology as a science of information. Large amounts of data
comprised of gene and protein sequences are now actively being sought out and shared
between scientists over the internet. Finally advances in high-throughput platforms for the
study of genomics, proteomics, and metabolomics have allowed the creation of massive
amounts of data (112). Recently, advances in proteomics have placed it at the forefront of
systems biology research (113, 114).
Proteomics is the study of proteins encoded by a genome, their modification,
dynamics and cellular function. The application of proteomics to systems biology follows a
logical research progression from DNA to mRNA to protein. While they provide a wealth
of information, mRNA levels only relate indirectly to protein levels, a balance between
synthesis and subsequent processing. Also mRNA levels cannot detect biologically
relevant changes at the protein level such as post translational modifications (PTMs),
spacial information, and interactivity of proteins. However there have been many
resources created for analyzing genomic data to discover gene or interactions and provide
gene enrichment data. Enrichment analyses use computational methodology to determine if
a set of genes or proteins exhibits statistically significant correlation to a specific function,
localization or biochemical pathway relative to chance. The ToppGene Suite provides
publically available tools for enrichment analysis that can be utilized to for enrichment

33
analysis, and display significant associations in molecular function, biological process,
cellular component and pathways (115). Detailed mapping of relevant protein pathways
can be accomplished using the KEGG database tools (Kyoto Encyclopedia of Genes and
Genomes) (116, 117). Another valuable tool for understanding protein interactions is
protein network analysis. The String database offers a publically accessible collection of
tools to mine known and predicted protein-protein interactions (118). At the time of our
research the String database contains information from 2,590,259 proteins across 630
organisms. These tools allow a user to examine a proteomics data set that can include
hundreds of responsive proteins to visualize interactivity and aide the investigator in
deciphering relevance within the biological system.
Chapters four and five represent a paradigm change to a holistic, systems biology
experimental design in contrast with the reductionist design in chapter two. Chapters four
and five are focused on elucidating the biochemical changes in the developing rat
cerebellum initialized by utilizing a peptide-centric mass spectrometry approach.
Bioinformatics allowed us to identify 662 responsive peptides to ETS treatment. Further
analysis divulged relevant biochemical pathways and cellular structure modulated by ETS.

CHAPTER 4
SYSTEMS BIOLOGY REVEALS ALTERED MITOCHONDRIAL
PROLIFERATION AND METABOLISM IN DEVELOPING CEREBELLUM
CONSEQUENT TO ENVIRONMENTAL TOBACCO SMOKE EXPOSURE
4.1. ABSTRACT
Postnatal environmental tobacco smoke exposure, ETS, has recently been linked to
behavioral and cognitive deficits in children. The functional domains found affected by
ETS are symptomatic of attention deficit hyperactivity and conduct disorders, which
represent a substantial mental health burden in the United States and abroad. New clinical
imaging on such diagnosed children reveals persistent evidence for abnormal morphology
and function in the cerebellum. Our study aims to test how postnatal ETS exposure can
alter the developing mammalian cerebellum, which may in part underlie the biological
bases for functional deficits in exposed children. In this study, ETS was administered
during the vulnerable period of postnatal rat cerebellar development. Using a label-free
proteomics approach, we identified 662 peptide measures with a statistically significant
response to ETS treatment. Bioinformatic tools were exploited to identify relationships
within, and interpret the biological relevance of the results. ETS responsive data
highlighted altered aerobic respiration, which was confirmed upregualted by orthogonal
measures, along with molecular evidence for increase mitochondrial biogenesis mediated
by dynamin 1 like protein. Molecular findings correlated with an ETS-induced two-fold
34

35
greater density of mitochondria within the cerebellum, observed by immunofluorescence
and electron microscopy. A healthy mitochondrial morphology was also confirmed by
electron microscopy with no discernible ultrastructural differences between groups. Results
were consistent with an ATP-demand driven rationale for the ETS induced upregulation of
aerobic respiration within an increased mitochondrial population. In all, this study
demonstrates the successful application of a proteomics-based, systems biology approach
to divulge novel neurobiology. Abnormal mitochondrial biogenesis in combination with
increased ATP demand during the critical time of cerebellar synaptogenesis points to
potential irregularity in synapse formation, which in future research may be found to
underlie functional deficits associated with mental health issues in children.

4.2. INTRODUCTION
Recent epidemiological studies have reproducibly found a dose-dependent risk for
behavioral and associated cognitive problems in children exposed to environmental
tobacco smoke (ETS), otherwise known as secondhand smoke (90, 119-124). Importantly,
their findings were found to be independent of prenatal exposure (smoking during
pregnancy) and in most cases were reported based on unbiased biofluid measurements,
alleviating criticism of earlier studies with similar findings (79, 86, 87, 125). Postnatal ETS
exposure was found to increase the incidence of inattention, hyperactivity, impulsivity,
written and spoken language deficits and conduct problems. The affect of ETS on those
domains was often assessed in direct association with diagnosed attentiondeficit/hyperactivity disorder (ADHD) and conduct disorder (CD), two comorbid mental

36
health concerns in children that may share an underlying neurological dysregulation (126,
127). Findings from the epidemiology show a consistent effect with up to a 9-fold
increased risk associated with postnatal ETS exposure dependent on the functional domain
assessed, level of exposure, gender and race. These studies clearly addressed a call by the
U.S. Surgeon General for further research (1), and concluded with the need to explore the
biological mechanisms underlying the relationship between ETS exposure during brain
development and functional deficits associated with ADHD and CD.
Preclinical research with in vivo models is instrumental to providing a foundation
of biological mechanisms linking postnatal ETS exposure with neurodevelopmental affects
(90, 121, 122, 128). Bias and confounding factors of cross-sectional epidemiological
studies can be controlled within the laboratory, with biochemical and cellular
measurements made directly on the mammalian brain following modeled ETS exposure.
To that end, we modified our in vivo ETS model (129) to provide postnatal passive
exposure to test an effect on the developing mammalian cerebellum. A growing body of
research demonstrates abnormal cerebellar morphology as one of the most prominent and
consistent clinical imaging features that distinguishes children with ADHD or ADHD
comorbid with CD from other children (104, 105, 130-134, 134, 134). The cerebellum,
while commonly associated with motor coordination, is now known to regulate behavioral
and cognitive functions through cerebello-thalamo-striatal-prefrontal cortex circuits.
Domains with cerebellar involvement include attention, planning, working memory,
spoken and written language and inhibition control (98, 100, 134-138), which match
deficits found modulated by postnatal ETS exposure and that underlie symptoms
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associated with ADHD and CD phenotypes (104, 139). Ultimately, there is a significant
population at greater risk for such mental health problems in the United States due to
postnatal ETS exposure. Consider that 50% of mothers who ceased smoking during
pregnancy resumed within six months of delivery; one in five U.S. children are exposed to
ETS in the home, 4.1 million under the age of 5; and that children under the age of 5 have
the highest exposure levels due to an increase in respiration rate and little control over their
environment (81, 140, 141).
The cerebellum is also distinguished by a late start to development relative to most
other brain regions in mammals, to include humans. Research pioneered by Dobbing et al.
established the precept of a vulnerable period for neurodevelopment. In humans, the
vulnerable period for cerebellar development extends a year or more following birth (142145), while the corresponding period in the rat extends out to 21 days from birth (146,
147). Animal research demonstrated dramatic cellular and functional affects on the
cerebellum if damaged during the vulnerable period that could not be recovered once the
period had closed, and that damage caused after this vulnerable period had less of an effect
on function (98, 106, 107, 110, 111, 136-138, 148-150). Altman et al. even found distinct
functional deficits depending on if the rat cerebellum was damage within the first or
second week after birth, which resulted in motor deficits or pronounced hyperactivity,
respectively (111). Thus, environmental exposure would likely have the greatest impact on
cerebellar development during the vulnerable period with potential long term functional
consequences.

38
In the current study, we applied a systems biology approach to test our hypothesis
that exposure to ETS during the rat cerebellar vulnerable period will result in measurable
biochemical and cellular alterations that can influence development. The findings herein
begin to build a foundation to discern the biological mechanisms by which postnatal ETS
exposure may induce childhood deficits with cerebellar involvement that are symptomatic
of ADHD and CD. We performed label-free proteomics as the foundation of our study to
define the ETS-responsive neuroproteome. A host of available bioinformatic tools were
exploited – enrichment analysis, pathway mapping and protein-protein network analysis –
to elucidate the biological response to treatment and begin to understand its impact on
cerebellar development. Our data interpretation was then substantiated by orthogonal
molecular measures and microscopic evaluation at cellular and sub-cellular levels.

4.3. EXPERIMENTAL PROCEDURES
Animal Procedures and Tissue Collection- Timed-pregnant Sprague Dawley rats
(n=8) (Harlan Laboratories, Indianapolis, IN) were order to allow five days of acclimation
prior to birth. Food and water were provided ad libitum except during exposure, when food
was removed. Litters were placed within a Teague TE-10 smoke exposure system (56) for
3 h per day until PD 21. The TE-10 system was operated as described previously with the
ETS concentration confirmed by daily gravimetric analysis of respirable suspended
particulate. Carbon monoxide levels were also affirmed at sub 10 ppm, non-hypoxic levels.
Litters were subdivided by treatment n=4 in the ETS exposed and room air only control
groups. Brain tissues were collected and snap frozen in liquid nitrogen three days after
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completed the ETS exposure, which allowed assessment of a lasting rather than a transient
effect of ETS just after the cerebellar vulnerability period would normally end. Animal
weight was recorded every 3rd day, with no statistical difference found between groups
throughout the study. All procedures conformed to the U.S. Public Health Service policy
with approval by the institutional Animal Care and Use Committee.
Sample Preparation- Collected cerebella were bisected at the sagittal midline with
one half processed by a three part protein extraction procedure. First, the tissue was
homogenized and incubated for 90 min at 4⁰C in an aqueous buffer absent detergents or
reducing agents but containing Complete Protease Inhibitor Cocktail (Roche Biochemicals,
Indianapolis, IN) and Phosphatase Inhibitor Cocktails 1 and 2 (Sigma, St. Louis, MO).
After centrifuging the homogenate at 15,000 g for 20 min the supernatant was collected
(Matrix Extract). Second, after washing the pellet, it was resuspended in an analogous
buffer with the addition of DTT (1 mM) and triton X-100 (1% v/v) and incubated for 90
min at 4⁰C before collecting the supernatant (Membrane Extract 1). The remaining pellet
was then washed and resuspended in 60% triton buffer / 40% isopropanol, incubated as
before, and then a third supernatant was collected (Membrane Extract 2). Protein
concentrations were determined using a Pierce 660 assay kit (Thermo Scientific, Rockford,
IL).
Cerebellum lysates, 100 μg each, were exchanged into 25 mM ammonium
bicarbonate (ABC), pH 8, containing 0.1% Rapigest surfactant (Waters, Milford, MA)
using Millipore Microcon YM-10 centrifugal filters (Billerica, MA) per manufacturer
instructions. Fresh DTT was added to a 5 mM final concentration and lysates were heated
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at 60⁰C for 30 min. After cooling, lysates were alkylated with fresh idioacetamide (15 mM
final concentration) for 30 min in the dark. Lysates were digested overnight with modified
trypsin (Promega , Madison, WI) at an enzyme to protein ratio of 1:100. Digests were then
vacuum-dried and reconstituted in 50 μL of 100 mM ammonium formate (pH 10).
Two-Dimensional Liquid Chromatography-Tandem Mass SpectrometryProtein digests (4 μL each) were sequentially injected in a treatment-interspersed order
onto a two-dimensional nanoACQUITY UPLC system (Waters) for tandem reversed-phase
(pH 10) / reversed-phase (pH 2) separation online with a Waters Synapt HDMS mass
spectrometer. Injected peptides were subdivided into 4 fractions using step-elution off of a
BEH130 300 μm x 50 mm C18 column and trapped onto a Symmetry 180 μm x 20 mm C18
column using 20 mM ammonium formate (pH 10) in water and acetonitrile mobile phases.
Trapped peptides were then gradient eluted off of a BEH130 75 μm x 150 mm C18 column
using 0.1% (v/v) formic acid in water (A) and 0.1% formic acid in acetonitrile (B) as
follows: 8% up to 30% B in 45 min, up to 50% B in 15 min, up to 85% B in 1 min, hold
for 4 min and then equilibrate back at 8% B for 15 min. Peptides were electrosprayed into
the mass spectrometer, which was operated in V-mode with a nominal resolving power of
10,000. An external standard of [Glu1]-fibrinopeptide B (100 nM) sampled every 30 s
facilitated accurate mass correction. Data were acquired via data-independent analysis
(151, 152), with a precursor ion scan (m/z 400 to 1,500) followed by a product ion scan
(m/z 100 to 1,500) each second. The instrument was mass calibrated daily using fragment
ions from the external standard with an RMS mass accuracy within 1.5 ppm. A standard
Ecoli tryptic digest (1 ug injected) was analyzed using a single 60 min gradient elution
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profile following each daily batch of samples for quality control assessment of system
performance prior to injecting the next sample batch.
Mass Spectrometry Data Processing- Continuum mass spectrometry data were
processed using Waters Protein Links Global Server (PLGS) software version 2.4 as
described elsewhere (153). During preprocessing, precursor and product ions above 250
and 100 count thresholds, respectively, were charge-state reduced, isotope deconvoluted
and accurate mass corrected. Product ions were time aligned to precursor ions within ±
0.05 min of their chromatographic peak apex and validated based on their chromatographic
peak width and the product to precursor peak area proportion. Preprocessed data were
summarized by monoisotopic reduced mass (MH+), peak apex retention time (RT) and the
combined chromatographic peak area for all isotopes and charge states. Ion tables for each
chromatographic fraction were merged combining data within ± 7 ppm mass and ± 0.5 min
RT tolerances, producing one ion table per protein extract, per biological sample. The
PLGS Ion Accounting protein database search engine parsed each ion table against a
UniprotKB Rattus Norvegicus specific fasta format database (2010_06 release) combined
with its reversed-sequence decoy entries. Parameters selected for trypsin specificity, one
missed cleavage, fixed carbamidomethyl cysteine modification, variable methionine
oxidation and neutral loss of ammonia or water. Serial searches were performed to
consider no additional post-translational modifications (PTMs), then variable
phosphorylation and finally variable glycosylation.
Alignment of Ion Tables Across Biological Replicates- Ion tables for each
sample (n=8) were aligned by precursor ion MH+ (± 7 ppm) and RT (± 0.5 min) utilizing
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the PLGS Expressions package (154). Aligned results were generated separately for Matrix
Extract data and Membrane Extract data, the later comprised of merged ion tables from
Membrane Extracts 1 and 2 that shared measures from a common sub-cellular origin.
Search engine results were superimposed the Matrix and Membrane ion tables, resolving
reproducible peptide identifications across biological replicates. Aligned ion tables were
filtered to select peptide measures quantified in  75% of biological replicates within a
group. Peak area values were collapsed together when split by experimental events such as
missed-cleavage, methionine oxidation and neutral loss. Afterward, a single biologicallyrelevant measure was reported under the MH+ and sequence of the most massive collapsed
entry. The cleaned Matrix and Membrane Extract ion tables were combined, and all entries
were defined by a unique identifier based on peptide sequence, its integer MH+ value and
the protein extract of origin. Data were sorted by their peptide score and filtered to an
estimated 1% false discovery rate using a decoy database method.
Statistical Analysis of Final Ion Table Data- Data were imported into the
quantitative proteomics package DanteR (ver. 1.0.1.0, Pacific Northwest National
Laboratory, omics.pnl.gov/software) (155, 156). Chromatographic peak area values were
log2 transformed and normalized (linear model), providing median-centered, normal
distributed peptide measures across biological replicates. Group-selective missing values
were identified; i.e., quantitative measure were absent from all biological replicates in one
group but present in replicates of the other group. Those non-random missing values were
deemed biologically relevant, symptomatic of a group-specific divide about the analytical
detection limit. Imputation values were simulated to reflect a Gaussian distribution about a
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mean equal to the minimum measure within the relevant group and having a distributed
proportional to the median empirical variance across all variables in that group (157, 158).
One-way ANOVA hypothesis testing was performed within DanteR using treatment as the
independent variable. The significance level (alpha) was corrected for multiple measures
(k=15,197) using an FDR method to control the family-wise error rate to 5% (159, 160).
Interaction Informatics- Measures found statistically responsive to ETS treatment
reflected putative modulation of protein or protein family abundance, localization or
modification. The ETS-responsive neuroproteome was summarized by Uniprot databasederived protein symbols, which correlate to HGNC stem symbols common across all
vertebrate species. Protein enrichment analysis was performed against GO annotation
terms (biochemical process and cellular component) and biochemical pathways accessed
from eight public databases using a Fisher’s inverse chi-square method with Bonferroni
correction (initial alpha 0.05) (ToppGene (115, 161)). Detail on enriched pathways was
assessed through the KEGG Pathway Database (116, 117). Proteins associated with the
GO term Mitochondrion (GO:0005739), the most significant enriched cellular component,
were analyzed further using protein-protein network analysis (STRING Database Ver. 8.3,
(162)) with the following parameters: a minimum interaction confidence score of 0.5,  10
interactors and impute ten intervening nodes. Network results were displayed in the
evidence view mode applying MCL clustering.
Immunoblot Analysis- Protein-balanced samples (n=4 per group) were resolved
using the NuPAGE gel system, 4–12% Bis-Tris gels and MOPS running buffer
(Invitrogen, Carlsbad, CA). Separated proteins were transferred to PVDF membrane
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(Millipore) via a semi-dry method. Membranes were probed with the following primary
antibodies: Hexokinase-1 (Sigma-Aldrich) at 1:400, adenosine triphosphate (ATP)
synthase 5A (Abcam, Cambridge, MA) at 1:1,000, Dynamin 1-Like Protein (Origene,
Rockville, MD) at 1:500, and calretinin (Abcam) at 1:1,000. IgG HRP-conjugated
secondary antibodies and the SuperSignal West Pico chemiluminescence detection kit
(Thermo Scientific) were used following manufacture instructions. Blots were imaged on
an Image Station 4000MM Pro CCD imager (Carestream Molecular Imaging, Rochester,
NY) with net gray-level intensity measured from 16-bit images. Statistical testing was
performed using a Student’s t-test method with correction for multiple-testing using the
Holm-Bonferroni method (initial alpha 0.05).
Immunofluorescence Microscopy- Fresh frozen cerebella were bisected at the
midline and mounted for sagittal sectioning starting at a depth of 1 mm from the lateral
surface. Cryosections (10 µm) were collected from cerebellar tissue, n=4 per group.
Sections were fixed in 3% paraformaldehyde, washed and blocked with 5% milk
containing 0.3% triton X-100. The mitofilin primary antibody (MitoSciences, Eugene, OR)
was diluted 1:500 (v/v) in blocking buffer and incubated overnight at 4⁰C. Alexa Flour
Dye conjugated secondary antibody (Invitrogen) was applied (1:1000) and incubated at
room temperature for 1 h in the dark. Sections were mounted in Vectashield soft set
medium containing DAPI stain (Vector Labs, Burlingame, CA). All sections were
visualized on a Zeiss AxioImager A1 fluorescence microscope utilizing identical
parameters. Images of the molecular layer, granular layer and white matter were captured
per section. Grouped by anatomical layer, images were deidentified and then sorted into

45
two groups by a blind observer for qualitative differentiation. Fractional area ROI analysis
was completed in ImageJ (163). Statistical testing was performed using a Student’s t-test
method with correction for multiple-testing using the Holm-Bonferroni method (initial
alpha 0.05).
Transmission Electron Microscopy- Sagittal sections from ETS and control
tissues were collected as above, but at a 50 µm thickness. Sections were fixed with 2%
glutaraldehyde, 2% paraformaldehyde in Millonig’s buffer for 60 min at 4⁰C and postfixed in 1% osmium tetraoxide for 2 h. Sections were then dehydrated, transitioned
through propylene oxide and then infiltrated overnight in Embed 812 (Electron
Microscopy Sciences, Hatfield, PA). Sections were flat-embedded between vinyl slides
and viewed via a light microscope to excise from the molecular layer. Thin sections (80
nm) were collected by ultramicrotomy onto copper 300 mesh Gilder thin bar grids
(Electron Microscopy Sciences), which were stained in lead citrate and uranyl acetate.
Micrographs were collected on a Jeol JEM-1230 transmission electron microscope
equipped with a CCD camera. Mitochondria per field were counted and encircled across
five micrographs per group using a stereological template within ImageJ (177
mitochondrial in total). Measurements included mean mitochondria area per group (Mito.
Area), mean Fractional Area (% of total field area occupied by mitochondrial) and the
number of mitochondria per field (Mito. Density). Statistical testing was performed using a
Student’s t-test method with correction for multiple-testing using the Holm-Bonferroni
method (initial alpha 0.05).
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4.4. RESULTS
Neuroproteomic Analysis- The research design summarized in Fig. 1 was
employed to test the effect of ETS treatment on the developing cerebellar neuroproteome.
Proteins soluble within the cytosol, neucleosol and mitochondrial matrix (Matrix Extract)
were resolved from membrane tethered or integrated proteins (Membrane Extract) using an
optimized multistep extraction protocol (164). The enriched subproteomes exhibited a
minimal 18% overlap, with 92% selectivity for known matrix-associated proteins and 81%
selectivity for known membrane-associated proteins. Results from label-free, dataindependent analysis included 138,212 raw precursor ion scan measures across group
replicates (Fig. 2), of which 41,840 were associated with a peptide sequence. Further
processing as summarized in Fig. 1B was required to remove redundancy and limit the
false-positive sequence identification rate.
Raw mass spectrometry results were confounded by experimental events such as
neutral losses, methionine oxidation and missed-cleavage; thus, reproducible, but
biologically redundant measures were collapsed under a single representative peptide ion
with the largest MH+. The split intensity data were summed for relative quantification of
biologically distinct measures between groups. Reduced peptide data contained unique
entries distinguished by their peptide sequence, MH+ and protein extraction source. These
data were then filtered to an estimated 1% false sequence identification rate using a decoydatabase method, providing the final list of 15,197 unique measures. Intensity values were
log transformed and normalized prior to ANOVA statistical testing. After
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Fig. 4-1: Experimental Workflow. A, Schematic of sample processing and ion data
generation steps. Replicate samples were processed using sequential protein extractions
followed by two-dimensional reversed-phase tandem mass spectrometry (2D-RPRPMSMS) of tryptic digests. Ion data were searched against a rat protein database, aligned
across all biological replicates and filtered for within-group reproducible measures. B,
Schematic of bioinformatics performed. Ion data were post-processed to collapse
biologically redundant ion measures, normalize ion area measures, impute for non-random
missing values and perform statistical testing. Results were assessed by enrichment,
pathway and network analyses, with biological interpretation substantiated by orthogonal
molecular and cellular measures.
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Fig. 4-2: Analysis of reproducible ion data confirms a significant response to ETStreatment. Based on over 105 reproducible ion measures, we were able to discern
quantitative data on 15,197 unique peptide measures distinguished by their sequence
(limited to an FDR of 1%), their reduced mass (delineates variably modified sequences)
and their extract of origin (matrix or membrane). Following ANOVA testing, 662 of the
unique peptide measures were discerned as statistically significant in response to ETS
treatment at a corrected alpha of 0.0049 using the Benjamini and Yekutieli FDR method to
limit the family-wise error rate to 5%. A volcano plot depicts the quantitative response to
ETS treatment. The number of responsive peptides was near-equally split between elevated
and lowered levels and one-third of responsive peptides were identified with a posttranslational modification.
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correcting the significance level for performing multiple measures (alpha = 0.0049 for an
estimated 5% type 1 error rate), 662 peptides were found as statistically responsive to ETS
treatment. The volcano plot in Fig. 2 illustrates the range of responses to ETS treatment.
The median group-mean difference among responsive measures was 2.3-fold with a lower
quartile cutoff at 65% change and an upper quartile cutoff at 5.2-fold change. The number
of increased and decreased ETS-responsive peptides was about even as expected from a
normal distribution, with 57% found within the membrane extract. 85% of responsive
peptides were found to be isoform specific relative to the target protein database. Of the
responsive peptides, 32% were identified as differentially phosporylated and 5%
differentially glycosylated.
Bioinformatic Analysis- An ETS-induced change in protein function may be
represented by one or more responsive peptide due to protein modification (e.g.,
phosphorylated or glycosylated), altered expression, altered catabolism or translocation
between spatial compartments (e.g., between matrix and membrane-tethered states).
Further, biologically induced responses will involve protein-protein interaction, whereby
significant biochemical events can be elucidated through the interactivity among
responsive elements. We thus employed several bioinformatic tools to reveal associations
within the ETS-responsive neuroproteome. Enrichment analysis was performed to identify
statistically overrepresented annotated biochemical pathways within the responsive data.
The results shown in Fig. 3A illustrate a concerted response among all protein pathways
involved in aerobic respiration, to include statistical overrepresentation
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Fig. 4-3: Enrichment and pathway analyses illustrate a prominent affect of ETS
treatment on aerobic metabolism. A, Protein enrichment analysis performed using the
Toppgene suite of bioinformatic tools identified statistically significant associations
between ETS responsive data and aerobic respiration pathways of electron transport chain
(ETC), glycolysis and the tricarboxylic acid cycle (TCA). Denoted p-values were
calculated using a Fisher’s inverse chi-square method with a Bonferroni correction of the
significance factor for multiple testing. The percentage of covered protein elements for
each indicated pathway is presented within parentheses. B, ETS-responsive proteome
superimposed the KEGG global metabolism reference map. Elements identified within the
responsive data are shown in bold red, and denote near-complete coverage of aerobic
carbohydrate metabolism.
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of electron transport chain (ETC), glycolysis and the tricarboxylic acid (TCA) cycle.
Superimposed the KEGG global metabolic pathways reference map, the ETS-responsive
neuroproteome exhibits a focused, near-complete coverage of aerobic carbohydrate
metabolism (Fig. 3B).
The ETS-responsive data were also enriched in mitochondrion-associated proteins
(28% of the ETS-responsive neuroproteome) tied with the GO term GO:0005739 (p =
5.33e-29). Associations amongst those proteins were further assessed by protein-protein
network analysis (Fig. 4), which revealed interactivity between and beyond that annotated
in traditional biochemical pathways. As expected from the enrichment analysis, enzymes
associated with pyruvate processing (e.g., TCA and associated metabolic side-reactions)
and ETC complexes (1, 2, 3 and 5) were well represented protein clusters. Phosphate
shuttling, chaperone and proteasome complex proteins represented three other major
protein clusters. Hexokinase 1 (Hk1), the loan glycolytic protein present in Fig. 4, is
known to traffic to and from the outer mitochondrial membrane to regulate glycolysis.
ETS Amplified Aerobic Respiration Machinery- Aerobic respiration within the
brain depends near-exclusively on metabolism of glucose to fuel oxidative phosphorylation
within mitochondria. Hk1 is the key regulator in the glycolytic aspect of this process, being
the first, rate-limiting enzymatic step of a chain reaction involving 9 other enzymes that
were also found responsive to ETS (Fig. 5A). Under ATP demand, glycolysis is regulated
by increased HK1 binding from the cytosol to the outer-mitochondrial membrane, whereby

55

Fig. 4-4: Mitochondrion-associated proteins enriched within the ETS-responsive data
denote a prominent effect on phosphate dynamics. Protein-protein network analysis
using the String Database bioinformatics package revealed distinct clusters associated with
the processing, use and shuttling of phosphate. MCL clustering was performed to define
protein-protein interactive groups as encircled and labeled. A large array of mitochondrialassociated proteins involved in the downstream processing of pyruvate were found
responsive, which provided the necessary input for oxidative phosphorylation via the
electron transport chain (ETC). Multiple components of ETC complexes 1, 2, 3 and 5 are
defined. Two protein clusters denote elements involved in chaperone and proteasome
protein processing that are ATP-dependent. Last, we observed a large group of proteins
involved in phosphate shuttling (e.g., phosphate exchanged across the mitochondrial
membrane, conversion of AMP to ADP or ATP to NTP).
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Fig. 4-5: ETS treatment induced an aerobic respiration-dependent increase in
glycolysis. A, Glycolytic pathway diagram with ETS-responsive elements colored in red.
Results were generated via imputing responsive elements into the KEGG pathway database
tool, depicting a response in all enzymes associated with the glycolytic pathway. Glucose
processing by hexokinase 1 (Hk1) is the rate-limiting step that is regulated by ATP
demand on mitochondria. B, Heatmap representation of ETS-responsive peptide measures
for Hk1, which denote a shift from a matrix to a membrane-tethered localization. P-values
calculated from ANOVA testing are denoted for each peptide measure. C, The
translocation of Hk1 was confirmed by orthogonal immunoblot analysis, with D, a
proportional decrease in the matrix extract and increase in the membrane extract of the
ETS group. (Mean ± S.E.M.) Symbols indicate significant differences from control
(*p≤0.015) by a Student’s t-test method with correction for multiple testing via a HolmBonferroni method.
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HK1 activity is increased. Such a compartmental shift is suggested from the profiles of
Hk1 responsive peptides. As illustrated in Fig. 5B., non-modified HK1 peptides are down
in the matrix and up in membrane extracts of the ETS group. Further, phosphorylated and
glycosylated HK1 motifs were found to be ETS responsive and may play a regulatory role
in this process. HK1 translocation was substantiated by orthogonal immunoblot results,
with a proportional decrease of cytosolic HK1 and increase of membrane-tethered HK1
(Fig. 5C & D).
Mitochondrial function is critical for meeting the ATP demands of the developing
brain. Figures 3 and 4 illustrate the sizeable overlap of the ETS-responsive neuroproteome
with TCA and ETC mitochondrial processes that culminates in oxidative phosphorylation
by ATP synthase (ATP5, ETC complex 5). ATP5 is the multi-protein complex that is
directly responsible for ADP to ATP conversion. Measures of non-modified ATP5
responsive peptides all exhibited heightened levels with ETS treatment and span across
nine ATP5 protein subunits (Fig. 6A). Immunoblot data confirmed a greater amount of
ATP5A with ETS treatment.
Taken together, the presented data indicate greater aerobic respiration capacity,
from HK1 through ATP5, in response to ETS-treatment. The compelling mitochondrial
association warranted further assessment. The rate of mitochondrial biogenesis in the
cerebellum is most rapid during the study period as required for initial neuronal process
outgrowth and synaptogenesis. ETS-treatment may modulate this biogenesis based on
synaptogenesis-induced demand or as an effect of reactive oxygenated species (ROS)
induced stress on mitochondrial integrity and function.
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Fig. 4-6: ETS treatment induced an increase in ATP synthase associated with greater
mitochondrial biogenesis/fission activity. A, Heatmap representation of ETS-responsive
peptide measures for ATP synthase (ATP5), which denote a concerted increase in nonmodified peptides associated with five different protein components of the complex. Pvalues calculated from ANOVA testing are denoted for each peptide measure. Immunoblot
data confirmed a statistically significant increase ATP5A over control. B, Heatmap
representation of peptide measures for dynamin 1 like protein (Dnm1l). Increased levels of
Dnm1l denote greater mitochondrial biogensis/fission activity. P-values calculated from
ANOVA testing are denoted for each peptide measure. Immunoblot data confirmed an
increase in Dnm1l within the matrix and membrane extract. (Mean ± S.E.M.) Symbol
indicates significant differences from control (*p≤0.015) by a Student’s t test method with
correction for multiple testing via a Holm-Bonferroni method.
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ETS-Altered Mitochondrial Biogenesis/Fission- Dynamin-like protein 1 (Dnm1l), also
known as Drp1, is critical to mitochondrial biogenesis/fission and influences trafficking of
mitochondria within developing neuronal processes (165, 166). Responsive Dnm1l
peptides (non-modified) concertively exhibited a greater intensity within the ETS group
(Fig. 6B). Dnm1l is primarily found in the cytosol, but a small quantity will bind to the
mitochondrial membrane to initiate the fission process. Immunoblot results confirmed a
greater Dnm1l abundance in the ETS group, up within matrix and membrane extracts by
125% and 43% over control, respectively. Phosphorylation is known to be involved in
signaling Dnm1l translocation. We observed reduced phosphorylation at serine 637 within
the ETS group (p = 0.026), a phospho motif known to exhibit an inverse correlation with
mitochondrial fission activity (167). Further, the ETS-responsive data did not highlight any
opposing fusion-associated factors such as mitofusin. Thus, the Dnm1l measures suggest
increased signaling and activity of mitochondrial fission in the absence of evidence for an
opposing process. Confirmation of an increased mitochondrial system response required
cellular observations.
The mitochondrial marker mitofilin was selected for immunohistological
assessment of cerebellar sections. Mitofilin was considered ideal in that it provided a
uniform staining across inner and outer aspects of the organelle and was known to be
uninvolved in mitochondrial fission and fusion dynamics (168). Mitofilin fluorescent
images were captured from the cerebellar white matter, the molecular layer and the inner
granular layer, which were all in flux during the study period (Fig. 7A). First, qualitative
differences between treatment groups were assessed in all three areas by a blinded

63

Fig. 4-7: ETS exposure induced a 2-fold increase in mitochondrial density with no
aberrant morphology. A, Representative micrographs of mitofilin immunofluorescence as
observed in the white matter (WM), molecular layer (ML) and granular layer (GL) of
cerebellum sections from ETS exposed and control groups. Scale bar: (in WM-ETS) 100
µm. B, Average fractional area measures normalized to control were calculated for the
three regions of interest from n=4 animals per group. C, Representative electron
micrographs of mitochondria within the ML for ETS and control groups. Outer
mitochondrial membrane and cristae morphology are consistant between groups and
appear healthy. Scale bar: 200 nm. D, Measures of fractional area, mitochondrial area and
mitochondrial density measured by counting and encircling individual mitochondrial
observed over n=5 replicate electron micrographs per group taken from within the ML.
Measurements were made on mitochondria within or bordering the upper and right-hand
edge of the stereological template. (Mean ± S.E.M.) Symbols indicate significant
differences from control (*p≤0.01) by a Student’s t-test method with correction for
multiple testing via a Holm-Bonferroni method.
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observer, in particular for the granular layer. Subsequent fractional area measures
substantiated statistically significant increases in mitofilin occupied area within the three
regions of interest (Fig. 7B), which was most prominent in the molecular layer at 2-fold
over control. Also, increased mitofilin staining was measured in the soma of Purkinje cells
(p = 0.007) with ETS treatment (data not shown). These data suggest an ETS-induced
increase in mitochondrial biogenesis/fission; although, an increase in mitochondrial size
would also result in greater mitofilin area measures.
Observations on individual mitochondria were resolved by electron microscopy.
Stereological measurements of mitochondrial counts and area were recorded within the
molecular layer. Relative to the total frame area, the fractional area occupied by
mitochondria was 2-fold greater in the ETS group (Fig. 7D), which was consistent with the
immunofluorescence data. Average mitochondrial size showed no statistically significant
difference between groups (n = 177 mitochondrial measures); whereas, the number of
mitochondrial observations within a given field (density) was significantly greater within
the ETS group. Morphology within both groups was consistent with a healthy appearance.
Analysis of mitochondrial ultrastructure revealed no discernible difference between groups
as confirmed by blinded experts (Fig. 7C). With no evidence for an association with
apoptosis in the neuroproteomic or microscopy findings, the greater mitochondrial
biogenesis/fission activity observed within the ETS group, evidenced by the presented
molecular and cellular results, is most consistent with an increased demand for ATP as met
by an assessed upregulation of aerobic respiration pathways.
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4.5. DISCUSSION
The experimental design outlined in Fig. 1 permits us to account for a range of
protein regulatory events in response to ETS treatment. Inherent to bottom-up proteomics
is the direct measurement of peptides, which provides information on post-translational
dynamics imperceptible to genomic studies. Altered expression, while important, is but
one of many proteomic responses to a stimulus. Post-translational modification and protein
translocation are two other important proteomic events considered in this study that
underlie altered function. Indeed, a full third of our ETS-responsive measures were
identified as phosphorylated or glycosylated (Fig. 2), which independently can represent an
important change in the regulation of a protein’s function. Results for Dnm1l are a good
illustration of the multi-faceted responsiveness to ETS treatment. The non-modified Dnm1l
peptides (Fig. 6) all exhibited an increase within the ETS group, while the serine 637
containing phosphopeptide was decreased. The former data suggested greater Dnm1l
abundance while the later is known to signify increased signaling for fission activity (169).
Taken together, these differential measures support one another in terms of their biological
relevance, despite the inverse quantitative response to ETS treatment.
Our experimental design also afforded rudimentary assessment of ETS-induced
spatial dynamics. Increased separation is well known to extend proteome coverage;
however, it is advantageous to consider fractionation steps that also retain information
pertinent to the biology, such as protein localization. Hk1 results aptly illustrate the insight
attained with even the most basic spatial discrimination. Data in Fig. 5 demonstrate the
altered partitioning of HK1 from a cytosolic to a membrane associated state in response to
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ETS treatment that would otherwise have been concealed without spatial separation. Hk1
translocation to the outer mitochondrial membrane governs the rate of glycolysis under
aerobic respiration (170).
Reproducibility and statistical stringencies were employed to control for random
and systematic experimental error. All measures were observed in 75% of biological
replicates, and samples were processed and analyzed in an experimental treatmentinterspersed order. Type I error was controlled such that of 662 ETS-responsive measures,
an estimated 33 were false detections and 7 had falsely indentified sequences. The
responsive data exhibited enrichment in isoform-specific peptides portending relevance to
the biology. A differential response of one individual member or an opposing response by
multiple members of a larger protein family could be diluted when assessed by common
peptide measures. Independent quantitative analysis of isoform-specific peptides provided
a more straightforward measure of dynamics among individual translated products (171,
172). We also recognized that some of the non-modified peptide measures were likely
confounded by uncharacterized, but potentially biologically relevant modifications. Aware
of the above, all responsive measures were considered as only putative indications of a
reaction by their parent proteins to ETS treatment. Relevance to the biology was based on a
concerted response elucidated through protein-protein interactivity.
Enrichment analysis revealed significant overrepresentation of aerobic metabolic
processes (Fig. 3). Further analysis of the ETS-responsive neuroproteome displayed nearcomplete coverage of all enzymes involved in aerobic respiration pathways (Figs. 3 & 4).
The initial regulator of those pathways is HK1, which was found to translocate from a
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matrix to a membrane associated state in response to ETS (Fig. 5). Heightened oxidative
phosphorylation activity is known to be regulated through recruitment of more HK1 to the
outer mitochondrial membrane, where it will utilize ATP derived directly from the
intramitochondrial compartment (170). The involved mechanism entails a change in the
conformation of the C-terminal binding sites of HK1, which is known to be affected by
ATP5 activity (173). In this way, the rate of glycolysis is physically coordinated with the
rate of oxidative phosphorylation at ATP5, providing for an ATP-demand dependent
regulatory link between the two under aerobic respiration. Results in Fig. 6 support this
link by illustrating increased ATP5 with ETS-treatment. ATP-demand driven HK1 activity
may also be regulated by post-translational modification (174, 175). A host of kinases and
phosphotases have been shown to act on HK1, altering its activity. To our knowledge, Fig.
5 presents two novel phosphorylation motifs and one O-glycosylated that may be involved
in regulating HK1 under aerobic respiration.
High ATP-demand is normal during neuronal process outgrowth and
synaptogenesis. Manufacture and vesicular transport of building elements to the neuronal
growth cone is ATP intensive. Chaperone and proteasome activities found responsive to
ETS treatment (Fig. 4) are two examples of ATP-dependent processes involved in neurite
extension. An upsurge vesicular transport activity happens as the axon approaches a target
and synaptic building blocks are focused. Synaptogenesis activity is proportional to the
rate of aerobic respiration. Hence, neurite outgrowth and synaptogenesis will affect the rate
of mitochondrial biogenesis (176, 177). Enrichment analysis showed the mitochondrion to
be the most ETS-responsive subcellular component. As neurites grow, there is a need to
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generate more, smaller mitochondria that can be easily transported. Then as synapses form
there is a surge in mitochondrial biogenesis to populate the pre- and post-synaptic
densities. Mitochondrial biogenesis/fission activity is controlled via Dnm1l, a GTPase
protein that forms a spiral structure that constricts and pinches a mitochondrion in two
(178). Upon examination of the neuroproteomic results, Dnm1l was the only mitochondrial
fission or fusion associated protein found to be responsive to ETS-treatment. Results
indicate ETS-induced calcineurin-mediated modification of and an increase in Dnm1l,
which are consistent with greater mitochondrial biogenesis activity (167).
There are at least two possible explanations for increased Dnm1l mediated
mitochondrial fission after ETS-treatment, both with potential functional implications for
the developing cerebellum. First, mitochondrial fission activity may be induced consequent
to increased biogenic demand, particularly by an ETS modulation of synaptogenesis that is
the most prominent cellular activity during the exposure period. Were this true, our data
would indirectly suggest that postnatal ETS treatment results in abnormal synapse
formation in the cerebellum or at least the timing thereof, which could contribute to
functional deficits. Li et al. recently demonstrated that overexpression of Bcl-XL increased
synaptogenesis and mitochondrial biogenesis in tandem through a Dnm1l mediated
process, further tying these two events together in development (179). Pharmacological
nicotine administration has also been shown to modulate synaptic plasticity, suggesting
that it may be at least one of the responsible components in ETS (180). Prenatal
administration of nicotine has long been shown to influence attention, activity and
cognitive functions associated with ADHD and CD as recently reviewed elsewhere (181);
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however, findings have been confounded by the dose, route and timing of administration,
limiting a clear clinical correlation with postnatal ETS exposure. The present study
addressed those limitations, administering a clinically relevant dose of nicotine as well as
the other active compounds contained in actual ETS via passive breaking, and during a
postnatal period of vulnerability for a brain region known to be involved in the
pathobiology of ADHD. We acknowledge that no model is a perfect correlate. The exact
timing cannot be exactly correlated between species and the rodent brain is well known to
differ in some respects from the human.
In the second scenario, stress-induced apoptotic cell death may underlie ETS
increased Dnm1l triggered mitochondrial fission as described in detail elsewhere (182184). Tobacco smoke condensate has been shown to induce mitochondrial dysfunction in
vitro accompanied by a significant perturbation to mitochondrial morphology with
increased ROS (21, 185, 186). Excessive mitochondrial fission with degraded morphology
and function is typical within a stress-induced pro-apoptotic environment as mitochondria
are broken down as part of controlled cell-death (169, 184, 187). Indeed, mitochondrial
dysfunction and excessive fission has been associated to a wide range of neurodegenerative
disorders, including Parkinson’s and Alzheimer’s diseases (166, 169, 187-189).
Ultimately, either scenario required examination at the cellular level to substantiate an ETS
effect on the mitochondrial population.
Mitofilin-stained mitochondria were assessed by immunofluorescence microscopy
(Fig. 7A & B). Qualitative analysis by a blinded observer revealed distinct differences in
intensity and distribution of the fluorescence between treatment groups. Quantification of
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the fractional area occupied by mitochondrial showed as much as a 2-fold increase that was
statistically significant in ETS over control within the white matter, molecular layer,
granular layer and Purkinje cell body. Immunofluorescence results, thus, substantiated a
pronounced affect of ETS treatment on mitochondria across all layers of the cerebellum,
implying an effect on granular and Purkinje cell types. However, additional data were
needed to confirm that the fractional area was increase due to a greater population of
mitochondria (i.e., fission activity) rather than a size increase (i.e., fusion activity).
Electron microscopy provided the decisive evidence for greater mitochondrial
biogenesis/fission activity induced by ETS treatment (Fig 7C & D). Measurements were
collected on individual mitochondria within the molecular layer. The results substantiated
a 2-fold increase in the number of discrete mitochondrial observations per area (Mito.
Density) within the ETS group, while average size remained unchanged. The
quantification was consistent with the immunofluorescence data, supporting that
mitochondrial biogenesis was increased across the cerebellum. Further, observations of
mitochondrial ultrastructure made by blinded experts were consistent with a healthy
appearance in both experimental groups. Absent evidence for abnormal mitochondrial
morphology or enrichment of apoptotic pathways within the ETS-responsive
neuroproteome, the first scenario was determined most applicable – that greater Dnm1l
mediated mitochondrial biogenesis along with upregulated aerobic respiration as
determined in this study were a likely consequence of ETs induced abnormalities in
cerebellar synaptogensis.
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In conclusion, results from this systems biology study demonstrate that ETS exposure
during the vulnerable period of postnatal cerebellar development resulted in as much as a
2-fold increase in mitochondrial biogenesis. The mitochondrial response was mediated by
an ETS-induced increase in Dnm1l, triggered at least in part through calcineurin
dephosphorylation of serine 637. Increased Dnm1l activity is known to be associated with
synaptogenesis, an ATP intensive process that is the likely driving force behind the
abnormal increase in mitochondrial biogenesis. Such a scenario is further support by the
increased regulation of aerobic respiration as evidenced through a strong enrichment of
associated pathways within the ETS-responsive neuroproteome and discrete HK1 and
ATP5 regulatory measures. Future research may find that maladaptive synaptic plasticity
within the cerebellum may indeed underlie a causal relationship between ETS exposure
and functional deficits symptomatic of ADHD and CD.

CHAPTER 5
SYSTEM BIOLOGY REVEALS ALTERED NEURONAL PROCESS
OUTGROWTH IN DEVELOPING BRAIN CONSEQUENT TO
ENVIRONMENTAL TOBACCO SMOKE EXPOSURE
5.1. ABSTRACT
A growing number of epidemiological studies suggest a causal association between
environmental tobacco smoke (ETS) exposure and behavioral and cognitive deficits in
children. The functional domains explored in these studies- behavioral and attentional as
well as language disorders are strikingly similar to those caused by perturbations of the
cerebellum during development. Using a systems biology approach our study aims to test
whether postnatal ETS exposure leads to altered biochemistry in the developing rat
cerebellum. Employing a rodent model of postnatal ETS exposure, we investigated
differences in the cerebellum neuroproteome of exposed animals relative to controls using
a label-free proteomic approach. From these data, we deduced 662 statistically significant
peptide measures responsive to ETS treatment. The corresponding ETS responsive
proteome was assessed with protein-protein network analysis. Clusters related to protein
processing, pre-synaptic transport vesicle activity, cytoskeletal structure dynamics, signal
transduction pathways and neurite growth and remodeling factors were discerned. Protein
enrichment analysis identified statistically significant associations of the ETS responsive
proteome with neuron projections, in particular axon associated proteins and synaptic
vesicles. Finally, immunotbloting and microscopy experiments substantiated altered
process outgrowth and synaptogenic processes. Taken together, the data depict a striking
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modulation in cerebellar formation consequent to ETS exposure that may, in part, be a
biochemical and cellular basis for behavioral and cognitive deficits observed in ETS
exposed children.

5.2. INTRODUCTION
Epidemiological studies have linked ETS exposure in children with increased
incidence of behavioral problems (87, 88, 190) and cognitive deficits to include language
disorders and attention issues (51, 79, 119, 191, 192). Most recently, the attention has
prominently focused on an association between ETS exposure in children and attentiondeficit and hyperactivity disorders e.g. ADHD (89, 90). Separate studies found that 50% of
ADHD children have poor motor control, which could be linked to a perturbation of the
cerebellum (102, 103). More recently MRI studies demonstrated that children with ADHD
have a reduced cerebellar volume relative to controls (104, 105, 133).The cerebellum plays
a critical role in coordinated activities beyond locomotion, into such cognitive domains
such as language disorders, dyslexia, inhibition of behaviors and attention deficits (98,
193, 194), which are functional domains previously suggested to be impacted by childhood
ETS exposure. Exposures during the neonatal period, such as to alcohol, have been shown
to perturb cerebellar development (91)(109). Further, insults to the cerebellum when the
molecular layer is forming, such as at PD10 or PD15 in rat, have induced hyperactivity,
which only resolves later in adulthood (104, 139). The overlap between functional domains
impacted by childhood ETS exposure and those with cerebellar involvement suggests a
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correlation, whereby ETS may alter cerebellar development that can result in disorders,
such as ADHD (134, 195).
The cerebellum stands out as a brain area with rapid post-term development, and
thus may have heightened susceptibility to post natal ETS exposure. Work by John
Dobbing et al. and others has established a critical time extending from the third trimester
as far out as 1.5 years after birth in humans when the cerebellum undergoes rapid
development, which has been defined as a vulnerable period (142, 144, 145). An
analogous vulnerable period in rats extends from birth to PD21, where damage to the
cerebellum resulted in sustained and functionally significant changes (110). During the
later 2/3rds of this vulnerable period molecular layer formation is taking place through
PD21. During maturation of the molecular layer, granular cells axons extend into the
molecular layer where they bifurcate to form parallel fibers. Synaptogenisis then occurs
between the parallel fibers dendrites of the Purkinje cells, which send out inhibitory axonal
projections as the major regulatory output of the cerebellar cortex.
In this chapter we further asses mass spectrometry data initially described in
Chapter 4. Further integration via bioinformatics tools has revealed responsive peptides
associated with altered neuronal process outgrowth, in particular axons, and associated
synaptogenisis. Presented are the new results along with additional supportive measures.

5.3. EXPERIMENTAL PROCEDURES
ETS exposure, tissue collection, lysate preparation and mass spectrometry
procedures are described in Chapter 4. Analysis of the mass spectrometry data utilized
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bioinformatics tools for protein enrichment (115) and protein-protein network analyses
(118) to identify interactions within our ETS responsive data.
Immunoblotting and immunohistochemsity procedures are described in detail
within Chapter 4. Membranes were probed with the following primary antibodies,
neurofilament-M (Invitrogen, Carlsbad, CA) at 1:20,000, CRMP2 (Abcam, Cambridge,
MA) at 1:20,000, N-Cadherin (BD Biosciences, San Jose, CA) at 1:1,000, MAP2
(Millipore, Billerica, MA) at 1:2,000 and calretinin (Abcam, Cambridge, MA) at 1:20,000.
Secondary antibodies utilized were stabilized peroxidase conjugated goat anti mouse and
anti rabbit (Thermo Scientific, Rockford, IL) at 1:1500. Bound antibodies were visualized
by chemiluminescence with either the SuperSignal West Pico or Dura kits (Thermo
Scientific) following manufacture instructions. Images were captured on an Image Station
4000MM Pro molecular imager (Carestream Molecular Imaging, Rochester, NY).
Quantitative evaluation of protein levels was performed via densitometric analysis of 16bit grayscale images using Carestream Molecular Imaging Software.
Immunohistorchemistry was performed for MAP2 (Millipore, Billerica, MA) at 1:1000
with AlexaFlour 588 fluorescence conjugated secondary antibody (Invitrogen) at 1:1000.
See Methods, Chapter 4 for further detail.

5.4. RESULTS
The associated proteins to all 662 responsive peptides (see Chapter 4) were
analyzed by protein-protein network analysis (Fig. 5-1), in Chapter 4 our earlier
assessment focused on mitochondrial associated elements. We visualized the results based
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on known action-based interactivity between responsive elements (e.g., reaction, binding,
modifying activity). The large cluster of peptides associated with metabolism was again
present, as explained in Chapter 4. However, we identified nine additional interactive
protein clusters.
Four of the identified clusters are involved with protein processing: (1) a group
involved in protein elongation includes multiple members of the elongation factor protein
family (Eef) and polyadenylate-binding protein 1 (PABPC1); (2) 40S ribosomal proteins
Rpsa and Rps3 that are involved in protein synthesis as well as six additional (data not
shown) responsive ribosomal proteins involved in mRNA processing; (3) a large group of
responsive chaperone proteins to include multiple heat-shock 70 (Hspa) and 90 (Hsp90)
family members; (4) lastly, multiple proteins associated with ubiquitin-proteasome activity
were responsive, to include UCHL1, UCHL3, Uba1 and seven components of the
proteasome (PsmX). Another cluster highlighted 20 pre-synaptic transport vesicle
associated proteins, involved in trafficking the building blocks required for axonal
elongation and guidance. In addition, we observed a larger cluster of actin (Act) and
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Figure 5-1: Protein-protein network analysis of the ETS responsive proteome.
Interaction networks of ETS exposure responsive proteins within the rat cerebellum.
Results were generated using the protein-protein interaction algorithm of the String
Database (162). Proteins associated with 662 responsive peptide measures were imputed
into the software. An action-based display was selected with a minimum correlation factor
of 0.5. The white nodes were added for enhanced interactivities. Biologically-relevant
protein clusters are highlighted and labeled, respectively.
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tubulin (Tubb) elements along with associated chaperones such as HSP90 and chaperonin
containing TCP1 complex (CCT) proteins that fold and stabilize actins and tubulins.
Proteins associated with signal transduction pathways were discerned. Rho family
GTPases, to include Ras-related C3 botulinum toxin substrate 1 and 2 (Rac1, Rac2), were
observed as well as Ras homolog gene family member A (RhoA). Rac1 and Rac2 play
important roles in signaling events required for axon growth (196, 197). In Fig. 5-1, RhoA
and one of its binding partners reticulon 4 (Rtn4), also known as nogo are observed
together. The binding of Rtn4 with its receptor Rtn4R will induce the RhoA-dependant
pathway resulting in neurite outgrowth inhibition (198, 199). Another signaling cluster
included mitogen-activated protein (MAP) kinases, specifically Mapk3 and Mapk1. Mapk3
can phosphorylate Mapk1 that in turn can regulated microtubule-associated protein 2
(Map2) via phosphorylation. Map2 is involved in microtubule assembly and plays a
important role in determining and stabilizing dentritic shape during development. Other
notable elements linked with the MAPK signaling cluster were microtubule-associated
protein Tau (Mapt) that is involved in microtubule organization within axons, and myelin
basic protein (MBP), which is known to exhibit developmental-specific isoform dynamics
during synaptogenesis and myelin formation.
The network analysis cumulated with a group of clusters related prominently to
various aspects of neurite growth. The first of these clusters contained proteins necessary
for process outgrowth. Notable elements included neural cell adhesion molecule 1
(Ncam1) and neural cell adhesion molecule L1 (L1cam), two proteins involved in cell-cell
adhesion that play an integral role in process development. Also seen in the neurite
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outgrowth cluster were two other adhesion proteins neurofascin (Nfasc) and contactin 1
(Ctn1), which play a role in process outgrowth and synaptic dynamics. A cluster of five
collapsin response mediator protein members (Dpysl/Crmp) was also observed.
Dpysl/Crmps are phosphoproteins expressed exclusively in the nervous system that are
integral to growth cone dynamics regulating extension and collapse. Also observed were
proteins associated with the Dpysl/Crmps. Growth associated protein 43 (Gap43) is
predominantly found in growth cones during development. The myristoylated alanine-rich
C-kinase substrate (Marks) proteins were found to interact with Gap43 and are regulated
by protein kinase C (PKC) observed in Fig. 5-1 as Prkcg. Lastly another protein regulated
by PKC was observed, Gamma-adducin (Add3), that is involved in the assembly of
spectrin-actin networks.
Subsequent to network analysis we further mined for related information by
enrichment analysis. We specifically inspected these results for enrichment association
with process outgrowth and synaptogenisis. Statistically significant associations were
identified with the following Gene Ontology cellular components: neuron projections,
axon associated proteins and synaptic vesicles (Fig. 5-2). While the overall coverage was
lower than enrichment observed for metabolism in Chapter 4, p-values indicated high
significance. The GO term Neuron projections contained elements of both dendrites and
axons. However, it was the specific GO term for axons was significantly enriched.
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Fig. 5-2: Protein enrichment analysis. Enrichment analysis was performed utilizing the
Toppgene suite of tools (161).From the results, we identified an enrichment of three GO
Cellular Components terms, which contained a statistically significant number of elements
relative to a random assortment. P-values from Fishers exact testing are included for each
term, and the percentage of term-associate elements found in our ETS-responsive data are
shown in parenthesis.
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Exposure to ETS affects Neurite Outgrowth in Cerebellum- Immunotbloting
results were generated to substantiate observations from the mass spectrometry data (Fig.
5-3). Neurofilament-M, an axonal marker expressed during development, was two-fold
greater in the matrix (soluble) fraction of the ETS group. N-Cadherin (Ncad) is an extracellular adhesion molecule that modulates synapse formation. We observed a six-fold
greater amount of Ncad in the matrix fraction of the ETS group, relative to the control
group. The pro form of Ncad is delivered to the growth cone via presynaptic transport
vesicles and is presented extracellularly where it can be cleaved and released during
synapse maturation (200). We also examined CRMP2 via immunoblot analysis, which if
phosphorylated by Rho kinase will inhibit CRMP-2 from associating with microtubules
resulting in growth cone collapse. In both the matrix and membrane fractions more pCRMP-2 was present in the ETS group, though the measurements did not reach
significance after multiple measure correction. Immunoblot analysis also revealed a greater
amount of Map2 in the ETS membrane fraction. Map2 is known to be elevated within
dendrites synaptogenisis (201) . We further examined Map2 via immunohistochemistry
(Fig. 5-4), which revealed an increase in Map2 staining specifically in the molecular layer
of ETS exposed cerebellum, corroborating our molecular results and localizing our
observation to the molecular layer.
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Fig. 5-3: Proteins related to neurite outgrowth as shown responsive by orthogonal
immunoblot analysis. (A) Immunoblots for proteins involved in neurite outgrowth in the
matrix and membrane fraction. (B) Normalized densitometric quantification of
immunoblot results with calretinin used as a loading control in both the membrane and
matrix fractions. Symbols indicate significant differences from control (*p≤0.02 and
**p≤0.001) by a Student’s t-test with a Holm-Bonferroni method correction for multipletesting.
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Fig. 5-4: Greater dendritic plasticity within the cerebellar molecular layer following
ETS exposure. An increase in Map2 density normalized to area was observed in the
molecular layer (ML) of cerebellar sections in the ETS (A) group relative to control (B).
Scale bar: (in A) A-B, 200 µm. Area normalized Map2 density was quantified from
matched sections of molecular layer (Mean ± S.D., n=3). Symbol indicates a significant
difference from control (* p=0.02) by Student’s t-test.
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5.5. DISCUSSION
At the peptide level, we observed a statistically significant decrease in isoform A of
Rtn4 within the membrane fraction, which suggest a reducing in the membrane tethered
state (202, 203). Recent evidence suggests that Rtn4-A will operate as a potent outgrowth
inhibitor and initiate growth cone collapse via a RhoA-associated signalsome in neurons
(204). In this process, extracellular Rtn4-A anchors the growth cone and is rapidly taken
up by neurons via a clatherin-independent process mitigated by EH domain-containing
proteins (Ehd’s). Indeed, we observed an increased level of Ehd1 within the matrix fraction
of the ETS treatment group. Disruption of the Ehd endocytosis mechanism will lead to
elevated membrane tethered levels of Rtn4-A and disrupts the outgrowth inhibition
function of Rtn4-A. Modulation of the Rtn4/RhoA signalsome may therefore result in
altered levels of membrane-tethered Rtn4 as indicated by our proteomic data, where the
lower level of membrane-tethered Rtn4 suggests greater activation of the inhibitory
function of the signalsome within the ETS group. Further confirmation of this was the
strong increase in RhoA at the peptide level, which is well known for its involvement in
outgrowth arrest and growth cone collapse (198, 205). Activated RhoA will result in Rho
Kinase (ROCK) activation that then can acts upon a range of substrates.
A novel, mammalian brain specific substrate of activated ROCK is profilin II
(Pfn2), which was found to be greater in the matrix fraction of the ETS group. Pfn2 is now
known to be a negative regulator of process outgrowth (206). Indeed Da Silva et al
demonstrated that Pfn2 is recruited to the processes via a RhoA/ROCK activation-
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dependent pathway. Following RhoA activation, ROCK complexes with Pfn2, which then
increases polymerized actin stability that inhibits neurite outgrowth and synaptogenesis.
Another relevant RhoA/ROCK substrate is CRMP-2, a member of the
dihydropyrimidinase-related protein family that as a whole (all five family members) was
responsive to ETS treatment. CRMP-2 phosphorylation by ROCK has been shown to
inhibit its association with tubulin and the recruitment to the growth cone as necessary for
microtubual elongation and axon growth (207). We further assess CRMP-2 by immunoblot
analysis (Fig. 5-3) and observed an increase in the phosphorylated form of the protein in
both the matrix and membrane fractions of the ETS group, though the measures did not
reach statistical significance after correcting for multiple immunoblot measures performed
with these samples. Elevated p-CRMP-2 is a further sign of inhibited axonal outgrowth
and growth cone collapse (208).
ETS responsive proteomic data also suggest that protein kinase C (Prkcg or Pkc)
may be more active and influencing a number of downstream effectors to further growth
cone collapse. The peptide data indicates a reduction in the soluble levels of Pkc, which
indirectly suggests that more Pkc maybe be membrane tethered where it is activated. In
particular, MARCKS protein was modulated by ETS treatment. We observed increase
phosphorylation of MARKS, which would dissociated it from the membrane, also
observed as a decreased level in the membrane fraction. We observed a similar trend for
the Pkc substrate fascin (Fscn1), which like MARCKS had increase phosphorylation and a
decreased amount in the membrane fraction of the ETS group relative to control levels.
While a differential phosphopeptide was not observed for GAP43, it was again lower in the
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membrane extract of the ETS group and is also a Pkc substrate. Taken together, these data
further the case for an increase in growth cone collapse involving Pkc phosphorylation of
multiple growth cone elements (209).
Map2 proteins are known to increase following neurite growth initiation and
remain elevated through dendritic outgrowth (210, 211). The function of Map2 is to
stabilize microtubules (MT) by cross linking MT with intermediate filaments and other
MT. Our data showed a greater level of MAP2 in the membrane fraction of the ETS group
(Fig. 5-3), which we confirmed to be localized to the molecular layer of the ETS group by
immunohistochemistry (Fig. 5-4). Elevated Map2 in the molecular layer suggest increase
plasticity in Purkinje cell dendrites. Given that Map2 levels subsequently fall during
synaptic maturation after PD 21 in the rat, our Map2 results suggest an immature dendritic
phenotype or an abnormal plasticity within the molecular layer. We further assessed PSD93 by immunoblot analysis, a post-synaptic density marker enriched in cerebellar Purkinje
cells that should associated with mature synapses. Results for the ETS group show a
dramatic range of biological variability not present within the control group. In two of four
smoke animals we saw a decrease in PSD-93 levels across two different bands relative to
control supporting a reduction in synapse maturation. However, the other two ETS samples
show a prominent increase in the lower of two observed bands suggesting a difference in
the modification state of PSD-93, which is known to be regulated by phosphorylation and
palmitoylation (212). While it remains unclear as to the significance between the PSD-93
band-pattern within the ETS group, what is clear is that the effect of ETS treatment on
PSD-93 is highly variable between individual animals.
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Results discussed thus far have suggested ETS induced growth cone collapse and
an inhibitory state to axonal outgrowth. However, there was a separate cluster of
responsive proteins that supported an increase in axonal guidance and adhesion
functionality after ETS treatment. A large number of L1 family adhesion molecules were
found responsive to ETS treatment. Ncam1, the most prominent was found increase in a
membrane tethered state as was L1cam and contactin 1 (Cntn1). The latter two L1
members were also found with reduced phosphorylation, supporting an extracellular
presentation, since phosphorylation by Map kinase 1 (Mapk1) would result in the
dissociation of these L1 molecules from actin and destabilization of their extracellular
presentation at the growth cone. Mapk1 was also found responsive, with less
phosphorylation and a lower amount recruited to the membrane suggesting less activity.
Neurofascin (Nfasc) was the only L1 family member found lower in abundance in the
membrane fraction of the ETS group, which may be a consequence of isoform dynamics
not resolved in our data. Indeed, Nfasc is unique in the L1 family by having many splicing
variants (179). Ncam1 and L1 Cam are both well known signal coreceptors in neuronal
migration and process outgrowth, and provide cytoskeletal linkage necessary for cell
growth cone motility (213). Thus, it remains unclear why their levels as well as that of
Cntn1 indicate an increase in guidance and adhesion at odds with other results suggesting
inhibited axon outgrowth and growth cone collapse. Another adhesion molecule not
directly related to the L1 family found elevated in the ETS group is N-Cadherin (Ncad). A
six-fold greater level of Ncad was measured in the matrix fraction of the ETS exposed
group indicating a greater abundance in the cytosol (Fig. 5-3). N-cadherin, while primarily
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known as a substrate-associated adhesion molecule, is also known to stimulate neurite
outgrowth as a soluble molecule in cerebellar neurons (214). N-cadherin is particularly
associated with axon guidance (215). Together with the L1 family dynamics, it seems
likely that there are two different processes at play within the cerebellum in response to
ETS treatment. One that is inhibiting axonal outgrowth with growth cone collapse that is
an abnormal effect of the exposure, while a second processes is trying to compensate by
maintaining high levels of guidance cues to attempt to complete synaptogenesis inhibited
by the first processes. Future studies will examine structural aspects of axons and synapses.
For example, neurofilament-M staining may allow us to visualize parallel fibers within the
molecular layer. We have already performed immunoblot analysis of NF-M, which
indicated an elevated level within the matrix fraction of the ETS group. The carboxyterminal tail domain of neurofilament-M is essential for the size and cytoskeletal
architecture of axons (216).
The results from this study depict a prominent affect of ETS treatment on a
cerebellum neural architecture. We have presented evidence of growth cone collapse and
inhibited axonal outgrowth induced by ETS treatment. We have provided evidence for a
concomitant immature dendritic phenotype. Other data suggests that the cerebellum may
be attempting to compensate by maintaining adhesion/guidance cues at a time point when
synaptogensis should be largely completed. Other biological processes involved in
synaptic development to include protein processing, cytoskepetal dynamics and
presynaptic transport vesicle activity are also found responsive to ETS treatment. Those
processes are all largely dependent on high-levels of ATP supported by increase aerobic
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respiration functionality. Future experiments will look to expand cellular characterization
of axonal and synaptic structures within the cerebellum; thus, further substantiating a miss
wiring in association with ETS exposure. Indeed recent studies are beginning to identify
dysfunction in synaptic plasticity within the cerebellum (217) and how cerebellar deficits
may be at least in part responsible for ADHD and other behavioral disorders in children
(134).

CHAPTER 6
CONCLUSIONS
6.1. THE EFFECTS OF ETS ON THE DEVELOPING RAT CEREBELLUM
In Chapter 4 we demonstrated an increase in mitochondrial proliferation as a result
of ETS exposure in the developing rat cerebellum. Absent of any abnormal morphology,
the increase in mitochondria is likely driven by an increased demand on aerobic
respiration. Further evidence in Chapter 4 also pointed to an increase in aerobic respiration
through increasing of glycolysis, the TCA and the ETC. Most telling was the translocation
of Hexokinase-1 from an unbound cytosolic state to a mitochondrial membrane bound
state, which happens only under increased utilization of adenosine triphosphate (ATP). In
Chapter 5 results depicted altered neuronal process outgrowth, specifically in axon
formation. Protein-protein network analysis of the 662 responsive peptides identified a
series of interactive protein clusters. A commonality between these clusters is their need
for ATP. For example, in protein synthesis ATP is required for aminoacyl tRNA
synthetase activity, which is essential for elongation of a growing peptide chain. On the
other hand, if proteins are being degraded rather than formed then ATP would also be
required. Ubiquitin-proteasome activity is highly dependent on ATP for ubiquitination,
recognition by the 19S regulatory particle and unfolding of the protein to be degraded. It is
fitting that we also observed responsiveness among various protein chaperones.
Chaperones function in protein-protein interactions such as folding and assisting in the
establishment of proper protein conformation. Heat shock proteins 70, 90 and chaperonin
containing TCP1 complex (CCT) proteins all utilize ATP as a regulator of their binding
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ability. No matter if a new protein is being synthesized or targeted for degradation, ATP is
required. ATP is also required for the formation of actin filaments and cytokinesis.
Presynaptic transport vesicles are dependent on ATP to fuel V-ATPases that in turn create
a proton gradient to allow for active transport. These results frame the question- what can
this increase in ATP demand in the ETS exposed group tell us about its possible phenotype
relative to the control group?
The development of the cerebellum begins after birth in rats and lasts until about
PD21. Chapter 3 detailed the vulnerable period in which the cerebellum is particularly
vulnerable to perturbations that can result in sustained and functionally significant
changes. From a metabolic standpoint this is also a time of increased utilization of aerobic
rather than anaerobic respiration. During this time of increased aerobic respiration, the
brain is rapidly increasing its synaptic density, utilizing an increased amount of ATP for
the formation of neurites, their refinement, and finally maturation of synapses. The
developmental increase in aerobic respiration eventually declines, leveling off during
adulthood. In Chapter 5 we presented evidence for a concomitant immature dendritic
phenotype and data suggesting that the cerebellum may be attempting to compensate by
maintaining adhesion/guidance cues at a time point when synaptogenisis should be largely
completed. Other biological processes involved in synaptic development, to include
protein processing, cytoskeletal dynamics and presynaptic transport vesicle activity, were
also found responsive to ETS treatment. Very telling is that those processes are all largely
dependent on high-levels of ATP supported by increased aerobic respiration functionality.
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Taken together Chapters 4 and 5 present strong evidence for an immature
developmental phenotype as a result of ETS exposure, with Chapter 5 describing the
immature phenotype and Chapter 4 presenting evidence for the greater energy demand of
an immature phenotype.

6.2. IMPLICATIONS OF ETS EXPOSURE IN ADULTS AND CHILDREN
Epidemiological data cited and Chapters 1 and 3 highlighted two populations which
appear most vulnerable to ETS exposure, children and the elderly. In both cases there have
been numerous studies which have linked exposure to ETS with neurological disorders,
namely dementia in the elderly, and ADHD/CD in children. Lacking in these studies are
defined biochemical/molecular/cellular pathways which are affected as a result of ETS
exposure. While epidemiological studies can determine the detrimental effects of ETS
exposure it us unable to elucidate the mechanisms by with ETS is harmful to these
vulnerable populations. A better understanding of the basic biology of ETS exposure in the
brain is paramount to developing possible treatment options, especially in children with
ADHD/CD. The overall scope of this dissertation research was to begin to elucidate the
biochemical and molecular effects of ETS on the adult and developing mammalian brain.
In this section I will speak to the implications of our research data as it applies to both our
adult and developing brain stories.
In Chapter 2 we presented evidence to apoptosis, gliosis and a possible
neuroprotective effect. Apoptosis has been previously observed in other tissues and in
culture as a result of ETS exposure. In the brain, increased apoptosis has been observed to
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be a hallmark of Alzheimer’s pathobiology (218, 219). Similarly we also observed an
increase in GFAP, a marker of gliosis, which is also common in Alzheimer’s pathobiology
(220-222). Alternatively ETS induced dementia could be as a result from downstream
cardiovascular effects which were discussed in detail in Chapter 1. Finally our adult study
observed an increase in β-synuclein, a protein known for its neuroprotective effects. βsynuclein has shown anti-apoptotic properties and has also been shown to restore the antiapoptotic function of α-synuclein, a key protein in Parkinson’s pathobiology. Smoking has
long been known to reduce PD incidence in a dose dependent fashion and the marked
increase in β-synuclein levels observed here may be a neuroprotective response to the
observed neuronal apoptosis. Our experimental findings in Chapter 2 begin to lay a
framework for a possible biochemical connection between ETS exposure and an
occurrence of dementia in an elderly population.
Chapters 4 and 5 presented data for the effects of ETS on the cerebellum during a
vulnerable developmental period. Epidemiological evidence has pointed to a reproducible
dose‐dependent risk for behavioral and associated cognitive problems in children exposed
to ETS. The effect of ETS on those domains was often assessed in direct association with
diagnosed ADHD/CD. However, like dementia in the elderly population, the biochemical
mechanism has remained unclear. In Chapter 4 we demonstrated altered aerobic
respiration, and a greater density of mitochondria within the cerebellum. Normal
mitochondrial morphology in the ETS exposed tissue lead to the theory that the increase
mitochondrial proliferation was not as a result of a stress response but instead appeared
consistent with an altered synaptogenic phenotype. Further data in Chapter 5 provided
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further evidence for an immature developmental phenotype as a result of ETS exposure.
The immature phenotype was characterized by axons and dendrites that appeared to be in a
plastic state and a lack of mature synapses. The current data shows signs of an
underdeveloped cerebellum as a result of ETS exposure during the vulnerable period. This
could then result in the ADHD/CD like phenotype, which if true, would potential mean
that we have taken the first step in understanding the biological mechanism by which
postnatal ETS exposure may induce childhood deficits associated with ADHD and CD

6.3. PROTEOMICS AND THE SCIENTIFIC METHOD
In order to evaluate the effectiveness of proteomics in my dissertation research, it
was useful to compare and contrast the experimental designs used to study the adult vs. the
developing rat brain. For both research projects the defined question was similar, testing
whether exposure to ETS results in a measurable change at the molecular and cellular
levels. The next step for both projects was to gather supporting information to create a
targeted hypothesis. The central hypothesis for the adult study was crafted around previous
findings form work associating tobacco smoke exposure with the central nervous system
(CNS). To that end, there was very little information relating ETS directly to the CNS.
However, I was able to obtain literature on ETS exposure for cultured cells and the cardio
and pulmonary systems. From the literature, I crafted the hypothesis that ETS exposure in
the adult brain would lead to altered biochemical effects due to gliosis, apoptosis and
damage caused as a result of an increase in reactive oxygen species. Literature pertaining
to the effects of ETS on the developing brain was also limited. I discovered a wealth of
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literature on epidemiological studies that helped provide evidence to the possibility that
ETS exposure during the critical neonatal phase causes functional perturbations in
cognitive and behavioral domains later in life. Without any a priori knowledge of any
biochemical or molecular effects, other than our adult study findings, we opted to adopt a
holistic, systems biology experimental design. In this approach, data from a large-scale
proteomic experiment would be mined to refine a working hypothesis for subsequent
targeted analysis. For example, analysis of the proteomic data framed the working
hypothesis that ETS exposure during a vulnerable period of cerebellar development would
result in excessive mitochondrial biogenesis, increased aerobic respiration demand and
modulation of cerebellar circuit formation. From here, projects reported in Chapters 4 and
5 followed similar paths as we tested our hypothesis via orthogonal methodologies such as,
immunoblotting and microscopy analyses.
Some points need to be discussed in comparing between the holistic, systems
biology experimental design of Chapters 4 and 5 in contrast with the reductionist design in
Chapter 2. In the adult study we were able to find changes in representative biomarkers for
apoptosis and gliosis. However we tried multiple markers of ROS and none of them had a
statistically significant difference between treatment groups. In the developing rat brain we
were able to repeatedly discover supporting evidence of our hypothesis via orthogonal
methodology. The application of proteomics for systems biology experimentation allowed
us to better define a specific hypothesis not solely based on the literature but from novel
data.
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While a very powerful tool, proteomics is not without its limitations. Many of the
computational resources used in the completion of this study in the developing brain were
originally designed for application to microarray experiments. Recent studies have
demonstrated a poor correlation between changes in mRNA levels and changes in the
protein level. Moreover, data collected at the peptide level can be more telling in terms of
PTMs, isoform specificity, and spacial locality. Quantification from proteomics data is the
collection of replicated measurements of the protein pieces themselves, the peptides.
However, a main limitation to mass spectrometry is the inability to detect all peptides from
a given protein of a complex protein mixture. This can be attributed to various technical
aspects of mass spectrometry experimentation. First is the limitation of detection on the
mass spectrometer. The detection capability has increased greatly over the years; however,
the ability to capture low abundance peptides remains difficult. Next is the effect of the
enzyme used to digest the complex protein sample. In our experiment trypsin was used to
digest the proteins into peptides by hydrolyzing the lysine and arginine residues. By only
using a single enzyme it is certain that some peptides would have been created that were
either too large or too small to be properly ionized and detected. The last limitation is that
all peptide identifications are based on matches from user defined peptide databases. As
noted in Chapter 4, the numbers of reproducible ions detected among our replicates was
large, but only a small percentage of those measured ions were identified. The unidentified
ions could have been a result of PTMs not selected in our search algorithm. Future
processing of the data, with target searches for PTMs beyond phosphorylation and
glycosylation could very well uncover additional peptide information. Also possible is that
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the corresponding peptide was not present in the database we used. The upside of the
database issue is that it is fluid, with new proteins and peptide sequences being added
daily. The successful application of a holistic, systems biology experimental design
provided a wealth of biochemical and cellular information for the effects of ETS on the
developing cerebellum. Furthermore, the effects seen were not predicted by the literature,
and therefore, might have gone unseen using a reductionist design.

6.5. INDIVIDUAL EFFECTS OBSERVED IN ETS EXPOSED RATS
One consistent observation was made during the course of both the adult and
developing brain studies. This observation was an increase in the variability in signal
intensity among the ETS exposed group relative to the control group during immunoblot
experiments. Initially the variability was associated with possible experimental error, with
the most likely culprit being unbalanced samples. However as can be observed from the
loading controls this did not seem likely. Also, this phenomenon was observed consistently
with various different antibodies (Figure 2-1, Figure 2-2). The observed variability led to a
non-significant difference between the ETS and exposed groups for those affected proteins.
We did not observe a similar increase in variability in our control groups. Furthermore, we
also observed this variation, albeit to a lesser extent in our developing rat studies, in
particular the immunoblot of PSD-93 a marker of mature synapses (Figure 5-3). In our
ETS group two animals showed a noticeable decrease in PSD-93 relative to the control
group. The variation can also be observed in the literature which has been discussed in
Chapters 1 and 3. In ADHD studies only 50% of those afflicted also showed motor
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deficiencies, and a large variance was observed among the behavioral studies which were
discussed in Chapter 3. We detected a slightly larger (0.08) increase in variance among the
quantitative values for the peptides derived from the ETS exposed cerebellum sample.
However, the variance did not have the same statistical effect on the data as found among
the above mentioned immunoblot experiments. This leads to the question of what could be
responsible for the observed variation. I believe the best evidence can be found in the
literature linking ETS to increase dementia risk, detailed in Chapter 1. These studies found
that in a population with cardiovascular vulnerability, ETS exposure can increase dementia
risk. I hypothesize that one cause for the increased variation in the western blot data is an
unknown, possibly cardiovascular related issue in the ETS exposed rats used in the study.
Future studies will most likely require a larger test population in order to determine the
extent of, and the further elucidation of the underlying cause of the observed variability.

6.5. FUTURE EXPERIMENTS
The studies in the adult and developing brain have showed that there is a
measurable difference between the ETS and controlled brains at the protein level. Now that
we have established that a difference can be measured we can now outline future
experimentation to further study the effects of ETS on the developing rat brain. One
concern that arose during our mass spectrometry study was statistical power. Due to the
fact that we were utilizing a new mass spectrometer we were unable to do a proper power
analysis to determine the number of animals needed to reduce the number of false
negatives. Our mass spectrometry results during the developing brain study showed a large
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variability between the two groups. In order to correct for this we chose a stringent alpha to
reduce our false positive detection rate. However due to the size of our population we also
increased the number of false negatives. During the statistical analysis our dilemma was
whether to decrease our alpha in order to increase the number of measurements or stay
with the corrected alpha which would lead to less measurements overall. We decided to
stay with our stringent alpha value which reduced our type I error to ~5% but provided us
with enough measurement to tell a biologically relevant story. Moving forward with the
ability to perform a proper Power Analysis we have found that we need to increase the
sample size from 4 to 6 animals per group. In regards to instrument sensitivity we were
quite impressed with the limit of detection of the mass spectrometer. Out of the 662
responsive peptides measured, 119 (18%) had a fold change of 7% or less. Our range of
detection ranged from as little as 7% to as high as 256% demonstrating the ability of the
mass spectrometer to accurately measure both large and small fold changes between the
groups.
Future experiments will also use a different exposure timeline to more accurately
match with human exposure. In rats the cerebellum develops completely after birth, but in
humans the cerebellum starts to develop prior to birth. In order to adjust our rat model to
match a post natal developmental time point we would move our exposure start time to
PD8. The vulnerable period in cerebellum development in humans closes when the
molecular layer matures which between eight months to one year. In rats this happens
around PD21. The new exposure timeline would better match a post natal exposure
paradigm in humans. Furthermore since our work has led us towards the idea of a
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developmental effect it would be of great interest to have more data from multiple time
points rather than a single snapshot at the end of the exposure period, this would allow us
to gain a better perspective of the development changes as they are happening.
Much of the literature cited in my dissertation has looked for, but has not been able to
determine a direct association between ETS and cognitive development. The same can also
be said for behavioral issues caused as a result of ETS exposure during neuronal
development. A strong possibility for this lack of a solid connection could be related to the
use of surveys for obtaining information. Clinical datasets may not always be reported
accurately and/or honestly. In order to eliminate bias, it would be valuable to utilize our rat
model for behavioral testing. Our animal model could be used to study both cognitive and
behavioral difficulties as a result of ETS exposure. Behavioral deficits such as irritability
and anxiety could be assessed by the determination of emotion changes in the test subjects
as a result of ETS exposure. Cognitive and behavioral difficulties associated with ETS
exposure will be measured using widely utilized and accepted paradigms within the field
of psychiatry. In particular, simple measures of movement and exploration could be
utilized to measure deficits in attention and or hyperactivity, which could provide valuable
data towards our ADHD hypothesis. It would also be beneficial to follow some rat pups
into adulthood for long term observation of exposure during the vulnerable period until
adulthood which would be ~PD58. Allowing some of the rats to mature into adulthood
could provide valuable information on long term changes in behavior, cerebellar structure
and the potential to witness a reverse of the hyperactivity deficit as discussed in Chapter 3.
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